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ABSTRACT
A system is presented for determining the 
relationships between structure and function in the 
allosteric enzyme 6-phosphofructo-l-kinase (PFK). The ATP- 
dependent phosphorylation of fructose 6-phosphate to 
fructose 1,6-bisphosphate catalyzed by PFK is the first 
reaction unique to the glycolytic pathway.
The structure-function relationships in PFK can now be 
addressed by site-specific mutagenesis. This is a method 
for directly testing hypotheses concerning the functions of 
individual amino acids in a protein molecule.
The main body of this dissertation is composed of 
three sections. The first two sections describe the 
development of a system by which the structure-function 
relationships in Bacillus stearothermophilus PFK (Bs-PFK) 
can be investigated using the technique of site-specific 
mutagenesis. The third section describes preliminary 
efforts made toward establishing a similar system for the 
PFK from rabbit muscle.
I. Nucleotide sequence of the 6-phosphofructo-1- 
kinase gene from Bacillus stearothermophilus and comparison 
with the homologous Escherichia coli gene: This section
describes the cloning and sequencing of the gene encoding
Bs-PFK. A significant degree of homology exists when the 
deduced amino acid sequence of Bs-PFK is compared with the 
sequences of rabbit muscle PFK or the major PFK from 
E. coli.
II. High-level expression of Bacillus stearothermo­
philus 6-phosphofructo-l-kinase in Escherichia coli: This 
section describes the subcloning of the Bs-PFK gene into a 
plasmid vector and the high level of Bs-PFK expression 
which results when this construction is introduced into a 
PFK null strain of E. coli. This high level of Bs-PFK 
expression completes the system required for determining 
the relationships between structure and function in Bs-PFK 
by site-specific mutagenesis.
III. Molecular cloning and sequencing of a partial 
cDNA for rabbit muscle 6-phosphofructo-l-kinase: The 
nucleotide sequence of the cDNA described in this section 
confirms corresponding portions of the genomic sequence for 
rabbit muscle PFK. The cloning of the rabbit muscle PFK 
cDNA fragment represents significant progress toward the 
long-term goal of using site-specific mutagenesis to 
determine the structure-function relationships in this 
allosteric enzyme.
I N T R O D U C T I O N
I. Overview
This dissertation summarizes the development of 
systems for determining the relationships between structure 
and function in the enzyme 6-phosphofructo-l-kinase [EC 
2.7.1.11, phosphofructokinase (PFK)]. PFK catalyzes the 
ATP-dependent phosphorylation of fructose 6-phosphate to 
fructose 1,6-bisphosphate. This reaction represents the 
first step unique to the glycolytic pathway, and the 
activity of PFK is therefore regulated by an array of 
physiological modulators.
The mechanisms by which PFK responds to intracellular 
metabolites in order to regulate glycolysis have been the 
subject of intensive biochemical research. This research 
has focused upon the attempt to relate the three- 
dimensional structure of the enzyme to its allosteric and 
catalytic functions. The main thrust of this dissertation 
is on the development of systems in which the function of 
key amino acid residues can be directly tested. In order 
to achieve this goal, we have used the techniques of 
molecular biology to build upon foundations which were 
established by more classical methods of biochemistry.
The advent of recombinant DNA technology has enabled 
the biological sciences to make great strides forward in
1
2only a few short years. One of the most basic applications 
of this technology involves the cloning and sequencing of 
genes. This is of fundamental importance to biochemists 
since the amino acid sequence of an enzyme can easily be 
deduced from the nucleotide sequence of its gene. Cloning 
and sequencing is therefore a valuable alternative to the 
more classical method of peptide sequencing. In practice, 
both methods are often used for determinating a single 
amino acid sequence since each method tends to compensate 
for shortcomings in the other.
A second application of recombinant DNA technology 
involves the amplified expression of cloned genes in the 
form of proteins. For example, it is now possible to 
express a cloned gene in Escherichia coli at levels 
representing up to 50% of the total soluble protein. This 
is again of fundamental importance to biochemists since 
proteins that were difficult if not impossible to isolate 
by classical separations can now be produced in abundance 
using recombinant DNA technology. High-level expression is 
particularly important to structure-function studies which 
require relatively large amounts of pure protein.
A third application of recombinant DNA technology is 
site-specific mutagenesis. This is a powerful technique by 
which defined changes can be made in the nucleotide 
sequence of a cloned gene. Site-specific mutagenesis is an 
important tool for enzymologists because it allows one to 
make predetermined changes in the amino acid sequence of a
3protein. Hypotheses concerning the function of a 
particular amino acid residue can now be tested' by changing 
that residue and analyzing the effect it has upon the 
enzymology of the "mutant" protein.
It is obvious that these applications of recombinant 
DNA technology are interdependent. In order to establish a 
system for performing site-specific mutagenesis on a 
particular enzyme; one must clone the gene for the protein, 
determine its nucleotide sequence, and express the protein 
product at reasonably high levels. The first two sections 
in this dissertation summarize the work involved in 
establishing a system for the site-specific mutagenesis of 
the PFK from Bacillus stearothermophilus. The third 
section describes preliminary efforts made toward 
establishing a similar system for rabbit muscle PFK.
II. Background
The following review of PFK will be restricted to the
ATP: D-fructose-6-phosphate-l-phosphotransferase which
catalyzes the transfer of Y-phosphate from ATP to the C-l
2 -
hydroxyl of D-fructose 6-phosphate (F6P ) to form ADP and
4-
D-fructose 1 ,6-bisphosphate (F1,6P2 )•
F6P 2- + MgATP2- F1,6P^“ + MgADP- + H+
This reaction is the first step which is unique to the 
glycolytic pathway. Glycolysis was the first major 
enzymatic pathway to be elucidated so it is not surprising 
that PFK has been the subject of intensive research.
P F K ’s can generally be classified into three groups based 
upon their molecular weights. The tetrameric bacterial 
P F K ’s have subunit molecular weights of 32 to 38 kDa, the 
tetrameric mammalian P F K ’s have subunit molecular weights 
of 7 5 to 95 kDa, and the octomeric yeast PFK’s have subunit 
molecular weights of 112 and 118 kDa (Evans et a l ., 1981). 
The PFK’s can be divided into two groups based upon their 
allosteric nature. The prokaryotic PFK’s respond to a 
rather limited range of physiological modulators while the 
eukaryotic PF K ’s are much more complex in their allosteric 
behavior.
PFK’s have been isolated in pure form from a wide 
variety of sources so a comprehensive account of all of 
them is beyond the scope of this review. General reviews 
on the subject have been made by Hofmann (1976) and Uyeda 
(1979), The following review summarizes information 
pertinent to the study of structure and function in the 
PFK's from B. stearothermophilus and rabbit muscle. These 
two enzymes are among the best characterized of all the 
known PFK's .
A. Prokaryotic PFK's
1. Structures of Bs-PFK and J?c-PFK-1
The PFK isolated from B. stearothermophilus (Bs-PFK) 
is a stable tetramer composed of four 34 kDa subunits. The 
primary structure of the enzyme was first determined by 
peptide sequencing (Kolb et al,, 1980). The same 
laboratory has also determined the crystal structures for
5the R-state (Evans and Hudson, 1979) and the T-state of the 
enzyme (Evans et al., 1986). The 2.4 X resolution which 
was obtained for the R-state was adequate to identify not 
only the tertiary structure but also the binding sites for 
the various ligands (Hellinga and Evans, 1985).
The major PFK from E. coli is a tetramer composed of 
four 35 kDa subunits and accounts for 90% of the total PFK 
activity in that organism. The amino acid sequences of 
Bs-PFK and the major PFK from E. coli (E'c-PFK-l) share a 
55% homology (Hellinga and Evans, 1985; French and Chang, 
1987). Furthermore, nearly all of the amino acids believed 
to play a critical role in the function of Bs-PFK are 
conserved in Fc-PFK-l (Hellinga and Evans, 1985).
The minor PFK (E'c-PFK-2) accounts for the remaining 
10% of the PFK activity in E. coli. This enzyme is a 
tetramer of four 36 kDa subunits and it is quite distinct 
from Fc-PFK-l in both its immunogenic (Kotlarz and Buc,
1977 ) and kinetic properties. Uc-PFK-2 does not display 
cooperative behavior and it does not respond to phospho- 
enolpyruvate. The enzyme has been referred to as the non- 
allosteric PFK from E. coli] however, it will display some 
inhibition by ATP (Kotlarz and Buc, 81) and fructose 1,6- 
bisphosphate (Babul, 1978).
2. Kinetics of Bs-PFK and Fc-PFK-l
The PFK from B. stearothermophilus displays 
cooperative kinetics with respect to fructose 6-phosphate 
but not with respect to ATP, and is subject to allosteric
6activation by ADP and inhibition by phosphoenolpyruvate 
(unpublished work of H. Hengartner cited in Evans and 
Hudson, 1979). The allosteric nature of Bs-PFK is 
therefore quite similar to that of the major PFK from E. 
coli (tfc-PFK-l).
The allostery of lfc-PFK-1 has been studied extensively 
(Blangy et a l ., 1968) and explained in terms of the model 
advanced by Monod, Wyman, and Changeux (1965). In this 
model, the enzyme can exist in two states: an active R- 
state and an inactive T-state. The difference between the 
two states of the enzyme can be characterized by either a 
differential in Vmax (V-system) or a differential affinity 
for the cooperative ligands (K-system). Bs-PFK has been 
characterized as a pure K-system since the two states 
differ in affinity for the homotropic and heterotropic 
ligands but not in Vmax (Evans and Hudson, 1979). For 
example, the binding of the cooperative substrate fructose 
6-phosphate by a single subunit can induce the entire 
tetramer to make the conformational transition from the low 
affinity T-state to the high affinity R-state. The 
sigmoidal dependence of Bs-PFK reaction rate on the 
concentration of fructose 6-phosphate has therefore been 
explained in terms of positive cooperativity.
3. Genes Encoding Bs-PFK and Ec-PFK-1
The gene encoding Bs-PFK has been cloned and sequenced 
by French and Chang (1987). The deduced amino acid 
sequence predicts a subunit molecular weight of 34,122 and
is nearly identical to the sequence which was determined by 
peptide sequencing (Kolb et a l . , 1980). The deduced 
sequence published by French and Chang (1987) corrects 
errors which were present in previously published amino 
acid sequences for Bs-PFK (Kolb et a l . , 1980; Poorman et 
al., 1984; Hellinga and Evans, 1985).
The gene encoding Ec-PFK-1 has also been cloned 
(Thomson et al., 1979) and sequenced (Hellinga and Evans,
1985). However, the nucleotide and deduced amino acid 
sequences for Ec-PFK-1 published by Hellinga and Evans 
(1985) contain a number of errors and the reader is 
referred to French and Chang (1987) for sequences which 
were revised according to a personal communication from 
Philip R. Evans (MRC, Cambridge, England). The gene 
encoding Ec-PFK-2 has been cloned (Daldal, 1983) and 
completely sequenced (Daldal, 1984). A mutant of the gene 
has also been selected which causes a high level of 
Ec-PFK-2 expression (Daldal, 1983).
4. Structure-function of Bs-PFK and EcPFK-1
The PFK from B, stearothermophilus is the only PFK for 
which crystal structures have been published (Evans and 
Hudson, 1979; Evans et al., 1986). Figure 1 shows 
schematic views of two Bs-PFK subunits in the Bs-PFK 
tetramer. By detailed analysis of the crystal structures 
for Ss-PFK, Hellinga and Evans (1985) have identified 31 
amino acid residues which appear to bind the various 
ligands of the enzyme.
8EMoclc*
•le
Fig. 1. Schematic views of two subunits in the Bs-PFK 
tetramer:: a, viewed along the z-axis; b, viewed along the 
x-axis. In each case, the other two subunits lie behind 
those shown. The alpha-helices are indicated by cylinders 
(1-13) and the beta-strands by arrows (A-K). The 
substrates ATP and fructose 6-phosphate are shown in the 
active site and the activator ADP in the effector site. 
(Taken from Evans et al., 1981.)
9Table 1 lists these 31 amino acids and describes the 
critical roles which they appear to play in the function of 
the enzyme. Table 1 also lists amino acids in Ec-PFK-1 and 
rabbit muscle PFK which may serve similar functions. The 
determination of the 3-D structure of Ss-PFK and the 
identification of 31 critical amino acids make Bs-PFK the 
best understood PFK in terms of structure-function 
relationships.
The four identical subunits of the JBs-PFK tetramer are 
related by three orthogonal dyad axes x, y, and z with 222 
symmetry (Evans and Hudson, 1979). The y-axis runs along 
the solvent filled hole through the center of the tetramer. 
The x- and z-axes define the two interface planes. The 
binding site for the cooperative substrate fructose 6- 
phosphate is located at the interface of subunits related 
by the z-axis. The activator ADP and the inhibitor 
phosphoenolpyruvate are bound at the same effector site 
located at the interface of subunits related by the x-axis. 
However, all of the amino acid residues involved in binding 
the substrate ATP are confined within each subunit.
The three-dimensional structure of Bs-PFK is therefore 
consistent with the kinetics of the enzyme. The hyperbolic 
kinetics of ATP binding follow a simple Michaelis-Menten 
pattern because this substrate is bound independently by 
each subunit. The cooperative ligands display sigmoidal 
kinetics because they are bound between adjacent subunits.
10
Binding site Residue in 
B.ilearo- 
ihtrmophitut
Residue type Comments
EC BS RM(N) RM(C)
A, fructose 6-phosphate Asp-127 Asp Asp Asp Ser catalytic residue
binding Arg-162* (r) Arg Arg Arg Arg binds 6-phosphatc
M et-169 Met M et Met M el hydrophobic contact to sugar ring
GIu-222 Glu Glu Glu Glu H -bond to 0 4
Arg-243* (r) Arg Arg Arg Arg binds 6-phosphate
His-249 His His His His binds 6-phosphatc
Arg-2S2 Arg Arg Arg Gin H-bond to  P 6 .0 2  nntl 0 5 , nlso ceiurnl to subunit 
interface
Asp-12 Asp Asp Asp Pro subunit interface
T h n l5 6 *  (r) Thr T hr Thr lie subunit interface
His-160* (r) His His His Thr subunit interface
B, ATP binding Ser-9 Ser Ser Ser Val contact to ribosc
Gly-11 Gly Gly Gly Ala main-chain amide H-bond to y-P
Tyr-41 TVr Tyr Tyr Phc contact to ribosc
Cys-73 Cys Cys Cys Thr main-chain amide and carbonyl H-bound to 
ribosc hydroxyls
Lys-77 Arg Lys Arg Lys hydropluibiceonliicl to adenine
Asp-103 Asp Asp Asp Phc possible interaction with Mg
Gly-104 Gly Gly Gly Glu main-chain amide H-bond to /7-P, carbonyl to 
0 1 '.  N o room for sidi-chuin
Glh-107 Met Gin Thr Glu possible H -bond to adenine N6
Lys-111 Arg Lys Thr Gin hydrophobic conlncl to adenine
Arg-171 Arg Arg Arg Gly catalytic residue (binds y-P)
C. effector site (ADP) Arg-21 • (p) Arg Arg Arg Arg H-bond to /1-P
Arg-25* (p) Arg Arg Arg Arg t-l-hund to a  mid /f-phusphalcs
Asp-59* (p) Asp Asp Met Gly inuin-clniin umidc M-bond lo /I-P. 
side-chuin H-bond to ribosc 0 3 ' und Arg-63
Arg-63* (q) Arg Arg Leu Gin H-bond to Asp-59, almost the only contact across 
the y-dyad
Arg-154 Arg Arg Thr Lys H-bond to /3-P
Giy-lS5 Gly Gly Gly Gly main-chain carbonyl H-bond to Mg
Glu-187 Glu Glu Asp Asp carboxyl H-bonds lo Mg
Arg-211 Lys Arg Thr Lys H-bonds lo  a-P and adenine N7. coupled with C 
terminus
Lys-213 Lys Lys Thr Lys H-bond to a-P
Lys-214 Lys Lys Arg Thr main-chain amide Il-bond lo ribosc 0 1 '
C terminus Tyr lie — (Val) H-bond to Arg-211
Table 1. A comparison of residues in the ligand-binding 
sites of three related PF K ’s: F’c-PFK-l (EC), Bs-PFK (B S ) ,
and the N-terminal and C-terminal halves of RM-PFK [R M (N ) 
and R M (C )1. Residues are listed under their number in the 
Bs-PFK sequence. Residues contributing to sites A and C 
are divided between neighboring subunits in the tetramer. 
Residues marked * are not in the subunit containing the 
main part of the site. The dyad symmetry axis relating the 
subunit containing these residues to that containing the 
main site are given as (p), (q) or (r). (Adapted from
Hellinga and Evans, 1985.)
Comparison of crystal structures for the R- and T- 
states of Bs-PFK suggests a physical basis for the 
cooperativity displayed by the homotropic effector fructose 
6-phosphate {Evans et a l ., 1986). The structural change 
between the two conformations can be described as a twist 
along the y-axis of symmetry. The twist from the T- to the 
R-state rotates one pair of subunits relative to the other 
in such a way that the fructose 6-phosphate binding sites 
are made more accessible.
The physical bases for the heterotropic interactions 
are more complex and less well understood. This is a 
challenging problem since the activator ADP and the 
inhibitor phosphoenolpyruvate bind to the same effector 
site with opposite effects. Comparison of the crystal 
structures for the T- and the R-states shows no detectable 
change in the effector site.
The crystal structures of Bs-PFK have been of great 
value in elucidating its structure-function relationships. 
However, it is important to remember that the information 
derived from X-ray crystallography is static rather than 
dynamic by its very nature. There is also the real 
possibility that the 3-D conformation of a protein in 
solution is significantly different from its conformation 
in the crystalline state. It is therefore important that 
the structure-function relationships deduced from the 
crystal structures of Bs-PFK be verified by independent 
means. Site-specific mutagenesis of critical amino acids
12
in Bs-PFK is perhaps the best way to achieve this goal.
The laboratory of Dr. Philip R. Evans at MRC 
(Cambridge, England) is currently using site-specific 
mutagenesis to investigate the structure-function 
relationships in the major PFK from E. coli. The gene 
encoding Bc-PFK-1 has been cloned (Thomson et a l ., 1979), 
sequenced, and expressed at high levels in E. coli 
(Hellinga and Evans, 1985). Evans’ laboratory at MRC is 
also working on crystal structures for both the T- and R- 
states of Bc-PFK-1 (personal communication). The MRC 
laboratory has recently used site-specific mutagenesis to 
probe the function of two amino acids at the catalytic site 
of Bc-PFK-1 (personal communication). They found that Asp- 
127 plays a key role in the rate enhancement of the enzyme 
by serving as a general base in the reaction mechanism.
They also found that Arg-171 plays only a minor role in the 
catalytic mechanism. These two residues are conserved 
between Bc-PFK-1 and Bs-PFK so it is likely that their 
functions in Bs-PFK are similar.
The gene encoding Bs-PFK has been subcloned into the 
plasmid vector pBR322 and expressed in E, coli at levels 
representing approximately 20% of the total soluble protein 
(Section II of this work, pp. 41-58). The cloning, 
sequencing, and high level expression of the gene encoding 
Bs-PFK have thus created a system in which structure- 
function relationships deduced from crystal structures of 
the enzyme can be tested by site-specific mutagenesis.
13
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B. Mammalian PFK Isozymes
1. Structure of Rabbit PFK Isozymes
The widely diverse requirements for glycolytic 
regulation in the tissues of higher animals are met by 
tetrameric combinations of three different isozymic 
subunits of PFK. These are the muscle (A in rabbit or M in 
human), liver (B or L) and brain (C or P) isozymic subunits 
of PFK (Foe and Kemp, 1985). The composition of the 
homotetramers and random heterotetramers is determined by 
the relative abundance of each subunit in a given tissue.
The PFK isolated from skeletal and heart muscle is a 
tetramer of A subunits, while the PFK isolated from liver 
and erythrocytes is a tetramer of B subunits. The PFK's 
isolated from most other tissues are made up of various 
combinations of the A and B subunits; however, the P F K ’s 
isolated from brain, thymus, and several other tissues 
contain the C subunit as well (Tsai and Kemp, 1973). For 
example, the molar ratio of the C, A, and B subunits 
isolated from rabbit brain is approximately 5:4:1.5 (Foe 
and Kemp, 1984).
The molecular weights of the three subunits are quite 
similar: 85 kDa for A, 80 kDa for B, and 86 kDa for C
subunits (Lee et a l ., 1987; Foe and Kemp, 1984). All three 
subunits are phosphorylated to some extent in vivo. This 
phosphorylation can be completed in vitro by the catalytic 
subunit of cAMP-dependent protein kinase (Foe and Kemp,
1984). ‘ Phosphorylation of the A isozyme (Foe and Kemp,
14
1982) or the B isozyme (Sakakibara and Uyeda, 1983) causes 
a minor increase in their sensitivity to allosteric 
inhibition. However, phosphorylation does not affect the 
specific activity or allosteric response of the C isozyme 
to ATP or fructose 2,6-bisphosph,ate (Foe and Kemp, 1984). 
The physiological significance of these observations has 
not yet been resolved.
The immunological relationships between the various 
rabbit subunits has been studied by Foe and Kemp (1985) 
using polyclonal antibodies. They found no cross- 
reactivity between anti-A serum and either the purified B 
or C subunits. They did find a small amount of cross- 
reactivity between the anti-B serum and the purified C 
subunits, but contamination of the original B antigen by C 
subunits could not be ruled out.
The PFK isolated from rabbit muscle (RM-PFK) is a 
tetramer composed of four identical 85 kDa subunits. The 
active tetramer can be dissociated by conditions such as 
low protein concentration, low pH, and low temperature. At 
neutral pH and low protein concentration (0.15 mg/ml), the 
enzyme activators tend to stabilize the tetramer while the 
inhibitors have the opposite effect (Lad et a l ., 1973).
RM-PFK is the only mammalian PFK for which a complete 
amino acid sequence is known at the present time, Poorman 
et a l . (1984) were able to determine 96% of this sequence
by the method of peptide sequencing. The uncertain 
positions and a gap of 30 residues in this amino acid
15
sequence were deduced by Lee et al. (1987) from the 
nucleotide sequence of the gene encoding RM-PFK. '
2) Kinetics of Rabbit PFK Isozymes
The kinetics of the rabbit PFK isozymes are perhaps 
the best studied among all the PFK's. Reviews including 
this subject have been made by Hofmann (1976) and Uyeda 
(1979). The large size of the mammalian PFK isozymes (more 
than twice that of the prokaryotic PFK's) reflects the 
complex allosteric behavior required to control the energy 
balance in specialized eukaryotic cells. The allosteric 
repertoires of the mammalian PFK isozymes include all the 
effectors of the prokaryotic PFK's (positive cooperativity 
with respect to fructose 6-phosphate, activation by ADP, 
and inhibition by phosphoenolpyruvate). In addition, these 
isozymes are activated by ammonium ions and fructose 
bisphosphates (fructose 1,6-bisphosphate and fructose 2,6- 
bisphosphate) while they are inhibited by ATP and citrate.
The most potent activator of mammalian PFK's, fructose
2,6-bisphosphate, was only discovered recently (van 
Schaftingen et a l ., 1980; Claus et a l ., 1981; Uyeda et al., 
1981). This effector controls the balance between 
glycolysis and gluconeogenesis by simultaneously activating 
PFK and inhibiting fructose 1,6-bisphosphatase. The level 
of this critical allosteric ligand is controlled by the 
bifunctional enzyme 6-phosphofructo-2-kinase / fructose- 
2, 6-bisphosphatase (El-Magharabi et al.,1982; Kountz et 
a l ., 1985). A single phosphorylation by cAMP-dependent
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protein kinase activates the bisphosphatase and inactivates 
the kinase functions of this enzyme. The cAMP-dependent 
protein kinase system thus links the regulation of 
glycolysis and gluconeogenesis to hormonal control by 
glucagon (Pilkis et a l . , 1982). However, the regulation of 
PFK and fructose-1,6-bisphosphatase is quite complex since 
one must also consider the roles of insulin (Kruep and 
Dunaway, 1984), adrenalin (Clark and Patten, 1981), and the 
anomeric specificities of the two enzymes (Younathan et 
a l ., 1981; Kelley et a l ., 1986).
The other allosteric effectors of the rabbit PFK 
isozymes are much less potent than fructose 2,6- 
bisphosphate in their effects. The major inhibitors are 
ATP (Lardy and Parks, 1956), citrate (Tsai and Kemp, 1974), 
and phosphoenolpyruvate (Kemp, 1971). However, the 
inhibition caused by ATP can be relieved by its own 
breakdown products (ADP, AMP, cAMP, and Pi) as well as by 
ammonium ions (Abrahams and Younathan, 1971) and fructose 
6-phosphate. Mammalian PFK's show cooperative kinetics 
with respect to fructose 6-phosphate and the curve for the 
concentration of this substrate versus relative velocity is 
therefore sigmoidal. In general, the activators of RM-PFK 
increase the apparent affinity of the enzyme for fructose 
6-phosphate and shift the sigmoidal saturation curve to the 
left. On the other hand, the inhibitors decrease this 
apparent affinity and thus shift the saturation curve to 
the right.
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The various tissues of higher animals require 
different types of glycolytic regulation. For example, 
muscle cells must be capable of increasing the rate of 
glycolysis in order to meet the demand for ATP under 
anaerobic conditions. Hepatocytes have very different 
requirements since they must be capable of carrying out 
gluconeogenesis in order to maintain blood glucose levels. 
These levels are critical to brain cells since glucose is 
their only available fuel under non-fasting conditions. 
Erythrocytes are another unusual case since they are unable 
to carry out oxidative phosphorylation and therefore rely 
upon substrate-level phosphorylation for their ATP.
The kinetics of the various PFK isozymes no doubt 
reflect the metabolic requirements of their source tissues. 
Foe and Kemp (1985) purified the three isozymic subunits 
from rabbit brain and allowed them to reassociate in order 
to obtain homotetramers composed exclusively of A, B, or C 
subunits. They found that the three isozymes all displayed 
sigmoidal kinetics with respect to fructose 6-phosphate.
The sensitivity displayed toward inhibition by ATP was of 
the order B>C>A and toward inhibition by citrate was of the 
order A>C>B. The A and B isozymes displayed equal 
sensitivity toward activation by AMP and fructose 2,6— 
bisphosphate. However, the C isozyme was considerably less 
sensitive than the other two isozymes toward these two 
activators. Foe and Kemp (1985) also noted that the 
kinetic properties of PFK heterotetramers are probably
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influenced by interactions between the different subunits 
since their kinetics cannot be predicted from the 
properties of the homotetramers.
3) Genes Encoding Mammalian PFK Isozymes
Lee et a l . (1987) have isolated a genomic clone for 
RM-PFK and determined the nucleotide sequence of all the 
coding regions. One-quarter of this coding sequence has 
been confirmed by a partial cDNA for RM-PFK (Section III of 
this work, pp. 59-77). The sequence of this cDNA also 
established the 3*-end of the RM-PFK mRNA. However, the 
genomic clone (Lee et a l ., 1987) terminates 61 base pairs 
upstream of the initiation codon of RM-PFK so the 5 ’-end of 
RM-PFK mRNA has yet to be defined.
Significant progress has been made in cloning the 
genes for the human PFK isozymes. Valdez et a l . (1987)
have used the RM-PFK gene to isolate a homologous clone 
from a human genomic library. Nucleotide sequence analysis 
of this clone has identified an exon which is identical in 
length and 87% homologous to the first coding exon of the 
RM-PFK gene. The deduced amino acid sequences of these two 
coding regions have an even higher 93% homology. It is 
therefore likely that the human genomic clone is for human 
muscle PFK although its strong bias towards adenine and 
thymine is indicative of a liver isozyme (Newgard et al.,
1986) .
Vora and co-workers have assigned the genes encoding 
the human M, L, and P isozymes to chromosomes 1, 21, and 10
respectively (Vora et a l . , 1982; Vora and Francke, 1981; 
Vora et a l ., 1983). They have also used a RM-PFK cDNA 
probe (Putney et a l ., 1983) to isolate a cDNA for human 
muscle PFK (Vora et al., 1986). This clone contains about 
500 base pairs of 3'-untranslated sequence and nearly 1350 
base pairs of coding sequence. The authors did not present 
any sequence data, but they claimed that the amino acid 
sequence deduced from the coding sequence of this clone was 
95% homologous with the published amino acid sequence for 
RM-PFK (Poorman et a l ., 1984).
Levanon et a l . (1986) recently isolated a genomic 
clone for human liver PFK by screening a library enriched 
for chromosome 21 sequences with two synthetic 
oligonucleotide probes. The sequences of these two probes 
were based upon peptide sequences of purified human liver 
PFK. The genomic clone for human liver PFK hybridized a 
3.5 kb band in Northern blots of human liver RNA and was 
capable of selectively enriching liver PFK mRNA by hybrid 
selection. However, no data concerning the nucleotide 
sequence of this clone was presented by the authors.
4) Structure and Function- of RM-PFK
Upon determining the nearly complete amino acid 
sequence for RM-PFK, Poorman et a l . (1984) noted that the
enzyme appeared to be a product of gene duplication and 
divergence since the two halves of the amino acid sequence 
shared a 32% homology. This confirmed earlier evidence 
that each RM-PFK protomer contained both heterogeneity and
duplication (Paetkau et a l ., 1968). Poorman et a l . (1984) 
also noted that the N-terminal half of the RM-PFK amino 
acid sequence was 44% homologous to the sequence of Bs-PFK 
while the C-terminal half was 34% homologous to Bs-PFK.
This finding and the evidence that the mammalian 
tetramer has D2 symmetry (Foe and Trujillo, 1980) led 
Poorman et a l . (1984) to suggest that the structure of an
RM-PFK tetramer resembled an end-on-end octomer of Bs-PFK. 
However, equilibrium binding studies indicated that there 
is only one catalytic site per RM-PFK subunit (Kemp and 
Krebs, 1967). This and the fact that RM-PFK responds to a 
greater number of allosteric effectors than Bs-PFK 
suggested that half of the catalytic sites on the 
hypothetical octomer of Bs-PFK had evolved into allosteric 
sites.
The amino acid sequence homology is greater between 
Bs-PFK and the N-half of RM-PFK than it is between Bs-PFK 
and the C-half. In addition, amino acid residues critical 
to the catalytic site of Bs-PFK (Hellinga and Evans, 1985) 
are conserved in the N-half but not the C-half of RM-PFK. 
It therefore appears that the C-half of RM-PFK has 
differentiated through time to assume an allosteric rather 
than a catalytic role.
Poorman et a l . (1984) proposed a tentative working
model for RM-PFIC in which each subunit resembles a dimer o 
Bs-PFK. The N-half of each dimer retains the catalytic 
role while the C-half assumes a regulatory role. Detailed
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amino acid sequence comparisons between Bs-PFK and RM-PFK 
suggested that what had originally been the fructose 6- 
phosphate binding site in the C-half of each dimer had 
evolved into an allosteric site for the fructose 1,6- and
2,6-bisphosphates.
Poorman et a l . (1984) went on to suggest that what had 
originally been the ADP activation site in the N-half of 
each dimer had evolved into an ATP inhibition site. The 
only evidence in support of this model came from limit 
digestions of RM-PFK with subtilisin (Gottschalk et a l .,
1983). These experiments indicated that the fructose 6- 
phosphate binding site and the ATP inhibition sites were 
located in the N-half of each RM-PFK subunit while the 
fructose bisphosphate and ADP activation sites were located 
in the C-half of each subunit.
The validity of this tentative working model for the 
tertiary structure of RM-PFK could be tested by the 
technique of site-specific mutagenesis. This would be 
accomplished by mutating amino acid residues thought to be 
important in the binding of various ligands.
Projects aimed at using site-specific mutagenesis to 
probe the active and allosteric sites of RM-PFK have been 
slowed by the difficulties associated with expressing the 
mammalian enzyme in E. coli. First, the length of the RM- 
PFK mRNA coding region is 2343 base pairs. A cDNA of this 
size is difficult to synthesize and clone into E. coli 
using conventional methods. Second, expression of RM-PFK
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would require that the cDNA be precisely inserted behind an 
E.coli promoter and ribosome binding site in a plasmid 
expression vector. The complexity of performing such a 
manipulation increases with the size of the DNA fragment to 
be inserted. Third, the codon usage in the RM-PFK cDNA may 
not be suitable for high level expression in E. coli. 
Finally, there is no guarantee that RM-PFK mRNA or protein 
will be stable in E. coli once they are expressed.
Considerable progress has been made toward the 
formidable task of performing site-specific mutagenesis on 
RM-PFK. The genomic clone for RM-PFK isolated by Lee et 
al., <1987) has provided the nucleotide sequence for all of 
the coding regions. In addition, the cDNA for RM-PFK 
cloned by French et a l . (Section III of this work, pp. 59- 
77) covers one-quarter of the RM-PFK coding sequence from 
the 3'-terminal end of the gene. The construction of a 
full-length RM-PFK cDNA may require the splicing of several 
such partial cDNA's.
I
SECTION I
Nucleotide sequence of the 6-phosphofructo-l-kinase gene 
from Bacillus stearothermophilus and comparison 
with the homologous Escherichia coli gene
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Nucleotide sequence of the 6-phosphofructo-1-kinase gene 
from Bacillus stearothermophilus and comparison with the 
homologous Escherichia coli gene
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Abbreviations: aa, amino acid(s); ADP, adenosine 5 ’-
diphosphate; ATP, adenosine 5'-triphosphate; bp, base 
pairs(s); Bs-PFK, Bacillus stearothermophilus PFK; Bs-pfk, 
gene coding for Bs-PFK; Bs-TyrTS, B. stearothermophilus 
TyrTS; Bs~tyrTS, gene coding for Bs-TyrTS; C, cytidine; d, 
deoxyribo; Bc-PFK-1, the major Escherichia coli PFK; Bc- 
pfkA, gene coding for Bc-PFK-1; Bc-TyrTS, B. coli TyrTS; 
Ec-tyrTS, gene coding for Bc-TyrTS; G, guanosine; kb, 1000 
bp; LB, Luria broth; nt, nucleotide(s ); PFK, phosphofructo- 
kinase; pfk, gene coding for PFK; RM-PFK, rabbit muscle 
PFK; RM-pfk, gene coding for RM-PFK; SDS, sodium dodecyl 
sulfate; SSC, 0.15 M NaCl, 0.015 M Naj-citrate, pH 7-8; 
TyrTS, tyrosyl-tRNA synthetase; tyrTS, gene encoding TyrTS.
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SUMMARY
The gene (Bs-pfk) for 6-phosphofructo-l-kinase (PFK) 
from Bacillus stearothermophilus has been cloned and 
sequenced. The deduced amino acid (aa) sequence is nearly 
identical to the sequence which was previously determined 
by peptide analysis. The elevated G + C content of Bs-pfk 
relative to the homologous Ec-pfkA from Escherichia coli is 
consistent with previous observations concerning genes from 
thermophilic prokaryotes. A significant degree Of homology 
exists when the deduced aa sequence of B. 
stearothermophilus PFK is compared with the corrected 
sequences of rabbit muscle PFK or E. coli PFK-1. The 
cloning and sequencing of Bs-pfk completes the first step 
toward using site-specific mutagenesis to investigate the 
structure-function relationships for this allosteric 
enzyme.
INTRODUCTION
6-Phosphofructo-1-kinase (PFK; EC 2.7.1.11) catalyzes 
the ATP-dependent phosphorylation of fructose 6-phosphate 
to fructose 1,6-bisphosphate. The activity of this enzyme 
is controlled by physiological modulators and it thus plays 
a key role in the regulation of glycolysis (Uyeda, 1979). 
PFK from B, stearothermophilus (Bs-PFK) and the major PFK 
from E. coli (Fc-PFK-l) share many physical and kinetic
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properties (Evans et a l . , 1981). They are homotetrameric 
enzymes composed of 34-kDa and 35-kDa subunits, 
respectively. Both display cooperative kinetics with 
respect to fructose 6-phosphate but not with respect to 
ATP, and they are subject to allosteric activation by ADP 
and inhibition by phosphoenolpyruvate. The PFK isolated 
from rabbit muscle (RM-PFK) is also composed of four 
identical subunits, but each of these 85-kDa subunits is 
more than twice the size of the prokaryotic PFK subunit.
The allosteric regulation of RM-PFK is more complex in that 
it is activated by AMP and fructose bisphosphates, while it 
is inhibited by ATP and citrate.
Poorman et a l . (1984) noted internal homology between 
the N- and C-terminal halves of a nearly complete aa 
sequence for RM-PFK. They also discovered homology between 
the aa sequences of Bs-PFK (Kolb et a l ., 1980) and the two 
halves of RM-PFK. This indicated that RM-pfk evolved from 
an ancestor of Bs-pfk by a process of gene duplication and 
divergence. Upon sequencing the gene for the major PFK 
from E. coli (Ec-pfkA), Hellinga and Evans (1985) noted 
significant homology between the deduced aa sequence and 
the sequences for RM-PFK and Bs-PFK.
This paper describes the cloning and sequencing of Bs- 
pfk and compares the deduced aa sequence with corrected 
sequences for Bc-PFK-l and RM-PFK. The strategy for 
cloning Bs-pfk was based upon genomic Southern blots 
which indicated that a 4.7-kb EcoRl fragment of
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B. stearothermophilus DNA hybridized with Ec-pfkA. This 
size-class of EcoRI fragments was isolated from a 
preparative agarose gel and ligated intp a XgtlO vector. 
Bs-pfk was isolated from the size-enriched phage X library 
by plaque hybridization using Ec-pfkA as a probe. 
Information from Southern blots was then used to subclone 
restriction fragments of Bs-pfk into M13mpl8 and M13mpl9 
for sequencing.
MATERIALS AND METHODS
(a) Bacterial strains, media, and methods
The source of the genomic DNA for the X library was B. 
stearothermophilus strain NCA 1503. This strain was 
obtained from the American Type Culture Collection 
(Rockville, MD) and grown in LB medium (Maniatis et al., 
1982) at 58°C. The dephosphorylated XgtlO arms and 
packaging extract used to create the genomic library were 
obtained from Promega Biotec (Madison, WI) under the trade 
names of Protoclone and Packagene, respectively. The E. 
coli host used for plating the X  library was strain K803 
obtained from Ross C. Hardison at Pennsylvania State 
University (University Park, PA) and grown in LB medium 
supplemented with 0.2% maltose and 10 mM MgClj* The 
M13mpl8 and M13mpl9 vectors as well as the JM107 and JM109 
hosts were obtained from Joachim Messing, presently at 
Rutgers University (Piscataway, NJ). The following methods
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were performed as described by Maniatis et a l . (1982) 
unless otherwise specified.
(b) Preparation of probes
Cloned Ec-pfkA was kindly provided by Philip R. Evans 
(MRC, Cambridge) as an M13mp8 subclone designated mHElOll 
(Hellinga and Evans, 1985). A 1.4-kb Hind.HI fragment 
containing Ec-pfkA was subcloned into pUC18 to create 
pUC18/Ec-pfkA. This recombinant was amplified and 
restricted with Hindlll to release the 1.4-kb fragment 
containing Ec-pfkA. The restriction digest was 
fractionated on a 1% agarose gel, the 1.4-kb band excised, 
and DNA purified by electroelution. The gel-purified 
fragment containing Ec-pfkA was nick-translated (Rigby et. 
a l . , 1977) to a specific activity of greater than 5 x 10^ 
cpm/pg for use in probing the initial genomic Southern 
blots. pUCl%/Ec-pfkA was nick-translated to a specific 
activity of greater than 5 x 10^ cpm/jug for use in probing 
subsequent Southern blots and plaque lifts.
(c) Genomic Southern blots
Genomic DNA from B. stearothermophilus strain NCA 1503 
was isolated by standard procedure (Schleif and Wensink,
1982) and purified by CsCl centrifugation. The genomic DNA 
was digested with a variety of restriction endonucleases, 
fractionated on a 1% agarose gel, and bidirectionally 
transferred to nitrocellulose. One Southern blot was 
probed with the nick-translated 1.4-kb Hindlll fragment 
containing Ec-pfkA at an empirically determined
hybridization temperature of 56°C. Nick-translated 
pUCl8/Ec-pfkA was used to probe the duplicate filter. The 
final and most stringent wash of each blot was done in 6X 
SSC/0.1% SDS for 5 min at 56°C. The autoradiograms of 
these two blots showed that the presence of vector 
sequences in the probe did not appreciably reduce the rati 
of desired signal to noise (data not shown).
(d) Construction of a partial genomic library
The genomic Southern blots indicated that Bs-pfk 
resided on a 4.7-kb ITcoRI fragment. Genomic .EcoRI 
fragments of this size were enriched before cloning into 
the vector XgtlO. B. stearothermophilus DNA (20 jJg) was 
restricted with EcoRI and fractionated on a preparative 
low-melting-point agarose gel. The bands from 4-6 kb in 
length were excised and purified (Schmitt and Cohen, 1983) 
on an Elutip-d column (Shleicher & Schuell, Keene, N H ).
The 4-6 kb EcoRI fragments were then ligated with 
dephosphorylated AgtlO arms and packaged to form viable 
phage using the protocols provided by Promega Biotech with 
their Protoclone and Packagene kits. The library was 
plated onto host strain IC803 and duplicate plaque lifts 
were probed with nick-translated pUCl%/Ec-pfkA at 56°C. 
Positive signals were obtained at a frequency of about 1 i 
500 and six independently positive clones were plaque 
purified. One of these clones (gtlO/Bs-pfk) was amplified 
by the plate lysate method (Huynh et a l ., 1985) and 
Southern blotted along with appropriate controls (Fig. 1).
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Fig. 1. Southern blot analysis of genomic and cloned Bs- 
pfk, DNA from the following sources was restricted, 
electrophoresed on a 1% agarose g e l , transferred to 
nitrocellulose, and hybridized with nick-translated 
pUCl8/Ec-pfkA. Hybridization was performed at 56°C and the 
most stringent wash was done in 6X SSC/0.1% SDS for 5 min 
at 56°C. Lanes: (1 & 18) 4 ng of mHElOll cut by Hindlll +
BamHl ; (2) 1 pg of E. coli genomic DNA cut by HpaI;
(3) 2 pg of B. stearothermophilus genomic DNA cut by EcoRI; 
(4-17) 100 ng of gtlO/Bs-pfk cut by; (4) EcoRI, (5) Sail,
(6) PstI, (7) SphI, (8) BamEI, (9) Sau3A, (10) Xbal,
(11) Hincl I , (12) Eindlll, (13) SstI, (14) lipnl, (15) .4ccl, 
(16) Smal, (17) EcoRI + Smal. The slight difference in the
migration between the genomic and cloned EcoRI fragments 
containing Bs-pfk (lanes 3 & 4) may be due to the 20-fold
difference in mass of loaded DNA.
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e) Sequence analysis
The gtlO/Bs-pfk clone was mapped by Southern analysis 
of single and double restriction enzyme digestions. 
Restriction fragments of Bs-pfk were isolated from low- 
melting-point agarose gels, subcloned into either M13mpl8 
or M13mpl9, and sequenced by the dideoxy chain termination 
method (Sanger et a l ., 1977). The sequencing strategy for 
Bs-pfk is shown in Fig. 2 and the completed sequence is 
presented in Fig. 3.
RESULTS AND DISCUSSION
(a) Nucleotide sequence of Bs-pfk
The 957-bp coding sequence of Bs-pfk (Fig. 3) predicts 
an aa sequence which is nearly identical to the revised 
sequence published by Poorman et a l . (1984) from the work 
of Kolb et al. (1980). The nt sequence codes for an Asp-12 
rather than Asn, a Gln-82 rather than Glu, and a Glu-95 
rather than Gin. These minor differences can be attributed 
to limitations of peptide sequencing. The deduced aa 
sequence of Bs-PFK predicts a subunit Mr of 34,122 which 
agrees reasonably well with the previous estimate of 33-kDa 
(Kolb et a l ., 1980).
The nucleotide sequences of Bs-pfk and Ec-pfkA are 
compared in Fig. 3. Their coding sequences share 58% nt 
and 55% aa sequence homologies. These values are quite 
similar to the values generated by a previous comparison of
Fig. 2. Sequencing strategy for the Bs-pfk gene. The 
1530-nt sequence shown in Fig. 3 is represented as a bold 
line with selected restriction sites. Only those sites 
used during subcloning are indicated. The arrow above the 
restriction map indicates the location and direction of the 
open reading frame encoding Bs-PFK. The first G of the GTG 
initiation codon corresponds to nt-139 in both Fig. 2 and 
Fig. 3. The arrows below the map indicate the location and 
direction in which the sequence data was read. The dideoxy 
chain termination method of Sanger et a l . (1977) as
modified by Biggin et a l . (1983) for [35s]dATP was used to 
sequence subclones in M13mpl8 and M13mpl9 (Norrander et 
a l ., 1983). Second-strand verification was obtained for 
86% of the coding sequence. In addition to the M13 
universal primer, two other sequencing primers were made on 
an Applied Biosystems Model 380A DNA Synthesizer. The 
sequence of the first 16-mer was identical to nt 549-565 
while the sequence of the second 16-mer was complementary
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Ba-pfk a a a a a a c t q a c c g a g c a c o g c t t t c c o t o c o t c o o c q t g c c o g o o a c o a t t q a c a a c o a c a t t c c g o q c a c t o a t t t t a c o a t c o o g t t t g a c
Ec-pfkA a t g c o t c t o a c c o a a a t o o o c t t c c c g t o c a t c o g t c t o c c g c g c a c t a t c g a c a a c o a c a t c a a a g c c a c t c ^ c t a c a c t a t c c g t t t c t t c
1 5 0  1 60 170
0 « - P F X  T h r A l a L a u A a n T h r V a l l l t A a p A l A l l a A a p L y a X l a A r t A B p T h r A l a T h r S a r H i a O l u A r i T h r T y r V a l l l a a i u V a l H a t G l y A r i
Ba-pfk a c g o c g c t c a a t a c g g t c a t t q a t g c c a t c o a c a a a a t c c g c q a c a c o g c o a c o t c g c a c g a o c g g a c q t a c o t g a t c g a a q t o a t o g g c c g c
Ec-pfkA A g T G C O C T O A Q C A C e Q T T O T A O A A O C O A T C G A C C Q T C T O C Q T Q A C A C C T C T T C T T C T C A C C A Q C Q T A r r t C C O T O f l T O O A A O T Q A T Q C Q C C G T
1 8 0  1 9 0  2 00
0 J - P F K  H l a A l a a i y A a p l l a A l a L a u T r p S a r G l y L a u A l a G l y O l y A l a O l u T h r l l a L a u I l a P r o O l u A l a A a p T y r A a p H a t A i n A a p V a l l l e
Bs-pfk C A T G C C Q O C O A C A T C G C C T T A T Q G T C Q O G G C T G O C C G G C O G G Q C G G A A A C O A T T T T A A T T C C Q O A A G C C O A T T A T Q A T A T O A A C G A C O T C A T C
Ec-pfkA T A T T O T G O A O A T C T O A C O T T O G C T O C O G C C A T T a C C G O T O G C T O T G A A T T C G T T O T G O T T C C G O A A G T T G A A T T C A Q C C G T G A A Q A C C T G G T A
2 1 0  2 2 0  2 30
0 a - ? F K  A l a A r g L e u L y a A r g G l y H l a G l u A r g Q l y L y a L y a H l a S a r l l f t l l a l l a V a l A l a G l u G l y V a l G l r S v r G l y V a l A a p P h a Q l y A r g O l n
Bs-pfk C C C C C C T T A A A O C O C O O C C A T G A O C O C G O C A A A A A A D A T A G C A T C A T C A T C G T G O C G O A A O O A G T T G G A A G C O Q C G T C G A C T T C G G C C G G C A A
Ec-pfkA A A C G A A A T C A A A O C G G O T A T C Q C O A A A G G T A A A A A A C A C G C G A T C Q T G G C G A T t A C C O A A C A T A T O T O T O A T G T T O A C G A A C t G O C G C A T T T C
2 4 0  2 5 0  260
0 « - P F K  I l « O l n G l u A l i ? h r 0 1 y P h a G l u T h r A r g V a l T h r V a l L a u a i y f t i B V * 1 0 1 f k A r i Q l y 0 1 y 3 « r P r 4 T h r A l « P h * A i p A r c V a l L a u A l a
Bs-pfk A T C C A G Q A A a c G A C C G O C T T T G A O A C a C G T O T G A C O G T G C T T G G C C A C Q T G C A G C G C G G C G O G t C O C C C A C G O C G T T T G A C C O C O T G C T C O C Q
Ec-pfkA A T C O A O A A A G A A A C C O G T C G T G A A A C C C G C G C A A C T O T G C T Q G O C C A C A T C C A O C G C Q G T O G T T C T C C Q Q T O C C T T A C O A C C G T A T T C T Q G C T
2 7 0  2 8 0  2 9 0
flf-PFK S a r A r g L f t u O l y A i a A r t f A l a V A l O l u L a u L t u L a u O l u G l y L y a G l y O l y A r g C y a V a l G l y l l a Q l n A a n A a n Q l n L a u V a l A a p H l a A a p
Bs-pfk A G C C O C C T C O O C G C C C G G O C G O T C Q A O C T G T T G C T C O A A G G A A A A O G C G G O C O C T G C G T C G G C A T C C A A A A C A A C C A G C T C G T C G A C C A T G A C
Ec-pfkA t c c c g t a t o g g c g c t t a c o c t a t c o a t c t g c t g c t g c c a g g t t a c g g c g g t c g t t o t o t a g g t a t c c a g a a c o a a c a g c t g g t t c a c c a c g a c
3 0 0  3 1 0  3 2 0
B a - P P K  I l a A l a G l u A l a L a u A l a A a n L y a H l a T h r l l t t A a p G l n A r g M e t t y r A l A L a u S a r L y a G l u L B u S a r l l a  *
Bs-pfk a t c g c g g a g g c g c t a g c c a a c a a a c a t a c q a t t o a t c a g c g q a t g t a c g c a t t o t c g a a a g a a t t g t c c a t t t a a g t c c c c a g g g g a a a q g a g
Ec-pfkA a t c a t c q a c q c t a t c q a a a a c a t q a a g c q t c c o t t c a a a q o t o a c t q q c t q o a c t q c q c c o a a a a a a t q t a t t a a
Ba-pfk a a g a c a a g a t g a a g c o o a a a a c o a a a a t c o t c t g c a c o a t c g g g c c g g c a a q c o a o a q c g t a o a c a a o c t g o t g c a a c t g a t g g a a g c g g g a a
oa-pfk t g a a c g t g g c g c g c c t a a a c t t t t c g c a c g g c g a t c a t g a a q a g c a c g g g c g g c g c a t c o c a a t a t t c g c g a a c g c g a a c a a c g g g c c g a a c g
Ba-pfk g t c g c c a t t t t g c t t g a c a c o a a a o q g c c g o a a a t c c g q a c q c a c g a a t a t g g a a a a c g g c g c c a t t g a g c t g a a q g a a g q g t c a a a g c t c g t
Ba-pfk c a t t t c g a t g a g c g a a t g c t c g g c a c g c c g g a a a a a a t t t c g o t c a c c t a t c c c a g c t t a a t c q a t o a t g t o t c c g t c g g c g c g a a a a t t t t g
Ba-pfk c t t g a t o a c q g o c t c a t c a g c c t g g a a g t c a a c g c g g t c g a c
Fig. 3. The deduced amino acid sequence of Bs-PFK, and the
aligned nucleotide sequences of Bs-pfk and Ec-pfkA 
(Hellinga and Evans, 1985). The numbers above the
sequences refer to the aa of Bs-PFK. The underlined 
corrections in the Ec-pfkA sequence were kindly provided by
Philip R. Evans. The Bionet Resource (Intelligenetics, 
Inc., Mountain View, CA) was used to assemble, analyze, and
translate the nt sequence of Bs-pfk.
the tyrosyl-tRNA synthetase (TyrTS) genes from B. 
stearothermophilus and B. coli (Winter et a l . , 1983). The 
two synthetase genes have 58% nt and 56% aa sequence 
homologies. The authors also noted an elevated G + C 
content of Bs-tyrTS relative to Ec-tyrTS, particularly in 
the third position of the codons.
TABLE I
G + C content of codons and percentage of codons with G or 
C in the third position for the pfk and tyrTS genes from B. 
stearothermophilus and E. coli
Gene
G + C 
Content (%)
Codons with 
G or C at 3rd Reference 
position (%)
Bs-pfk 58. 5 71 . 3 Fig. 3
Ec-pfkA 53.6 57.5 Hellinga & Evans (1985)
Bs-tyrTS 55 . 1 68.0 Winter et a l . (1983)
Ec-tyrTS 51.6 59.6 Barker et a l . (1982)
Table I shows the percentage G + C content and the 
percentage of codons containing G or C in the third 
position for the pfk and tyrTS genes from B, 
stearothermophilus and E. coli. It demonstrates that the
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G + C content of the two genes from the moderate 
thermophile is increased relative to that of the genes from 
the raesophile. The difference in G + C content is 
primarily due to a preference in B. stearothermophilus for 
G or C in the third position of its codons. This finding 
supports the idea that higher G + C contents help stabilize 
nucleic acid interactions in thermophilic organisms (Kagawa 
et a l ., 1984). In this context it is interesting to note 
that codons of the 3-isopropylmalate dehydrogenase genes 
from Saccharomyces cerevisiae (mesophile), Bacillus 
coagulans (facultative thermophile), and Thermus 
thermophilus (extreme thermophile) have third position G +
C contents of 39.6, 56.3, and 89.4%, respectively 
(Sekiguchi et a l ., 1986). The third position G + C content 
in thermophilic prokaryotes therefore appears to be 
positively correlated with optimal growth temperature.
(b) Comparison of three related PFK aa sequences
The deduced aa sequence of Bs-PFK has been aligned 
with the corrected aa sequences of ITc-PFK-l and the two 
halves of RM-PFK in Fig. 4. The 319-aa residue comparison 
between Bs-PFK and the N-terminal half of RM-PFK has a 44% 
aa sequence homology, while the 307 residue comparison 
between J3s-PFK and the C-terminal half of RM-PFK has a 35% 
homology. The homologies show that the three enzymes are 
clearly related and suggest that RM-PFK evolved by a 
process of gene duplication and divergence (Poorman et a l ,, 
1984 ) .
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Rt-PFK iW> T H B E H H A A R T L O
Ed- PFK-1 K I X K I O V l T S O O D A P Q H M A I R C V V R S A L T B O L E V H O i y D G Y L O L n D  R H V Q L D R Y S V  
Eft-FFX H K R I O V L T 3 C O P . S P C K N  A A 1 R S W R K A  I Y H O V K V Y O V Y H Q Y A O L I  A G  N I K K L B V G D V
fW-PFK V  G  K  A 1 A  V  L  T  8 Q  O II A  Q  O  H  N A  A  V  R U  V  R  V  G I F  T  0 A  R  V  F  F  V  H E 0 Y Q 0 L  V  D 0 G D  H  R  E A  T  U E S  V
RM-PFX (C} A V H H V O A P A A O H N  A A V R S T V R I O L  I f l O N R V L V V H D O F J G E A K O  Q l B B A O V S Y V
I 10 20 90 40 50
JEb-FFX~l S D H I M R O O T F L O a A R C P E F R D E H l R A V A I E M L K K E O I D A L V V I G f i D O  S Y H G A H
fe-FFX O D I I H R O O T J L Y T A R C P E P X T E H O f t K K O l E Q L K K H O I l G L V V I O O D O  S Y Q G A K
Rt-PFK (H) S K H L Q L a O T V I O S A R C K D P R E R E G R L R A A H U V K R G I T H L C V l O O D O  S L T O A D
Rt-pnc (C) G Q U T Q Q a a s K L O S K R T L P X K S F B  ft i  a  &  U l I K t t i l f t f t k v i i t t f t . t J . A . i i G a i i B . i i H B Q R K  60 70 SO 90 100 no
fo-PFK-1 R L T S H O  P  P C  I 0  L  P  0  T  I 0  H  D  I K  0  T  D  Y  T  I G  F  P  T  A  L  S  T  V  V
B#-PFK R L T E H O  P P C V O V P O T X D N D I P O T D P T I O F D T A L H T V 1
RM-PFK (H) T F R S B W S D L L S D L Q K A O K I T A E E A T R S S Y L H I V Q L V G S I D N D P C O T D H T I C T D S A L H R I T  
RM-PFK |C) Q P D E L C  I P F V V I P A T V 8 H H V P 0 3 D P S V C A D T A L N T I C
120 130 H O
&S-PFX-1 E A I D R L R D T S S S H f t f t  I S  V  V  I  V  H  0  R  Y  C  O  D  L  T  L  A  A  A  I A  0  0  C  B  P  V  V  V  p  B  V  B  F  S R  8  D  I  V  H  E U
B*-PFK D A I D K I R D T A T S H B R  T  Y  V  I I V H  0  R  K  A  0  G  I A  L  V  S G  L  A  0  O  A  E  T  I L  I P  B  A  D  Y 0  H  H  D  V  I A  R  L  K
RM-PFK (N> E I V D A I T T T A Q 8 H Q R  T  P  V  L  E V  h  O  R  H  C  0  Y  L  A  L  V  T  B L  S C  O  A  D  W  V  F  I P  B  C  P  P  D  D  H  W  B  D  H  L  C  R
RM-PFK (C) T T C D R I K O I A A G T K R B V P I  I I T H O O Y C O Y L A T H A O L A A O A D A A n P B E P F T l R D L Q A K V B  
150 150 170 ISO 190 200
fi>PFK-l A O I A K O K K H  A  I V  A  J T  E  H  H C O  V D B U H P I  E K E T O  R  E  T  R  A  F  H  0  H  I Q  R  G  0  S
a*- PFX R G D B R O K K H  3  I I I V  A  E C  V O S O V D  F O R Q I Q B A T O  F B T R V T V L Q H V Q R O O S
RM-PFK (H) R L 8  E T R T R 0 8 R L H  I 1 1 V  A B O  A l  D & H G X P I  T 3 E G  V K D L V V R R L G  Y D T R V T V L O H V Q R O O T
RM-PFX (C) h l v q k m k t t v k r c l v l r n e k c s e h y t  t d f i f n l y s e e o k o i f d s r k k v l g h h q q g g s
210 220 230 240 250
& - F F X - 1  P V P Y D R I  L A 8 R H G A Y  A I D L L L A G Y G O  R C V G I Q  K E Q L V H H D I  I D
A»*FFX P T A F D R V L ^ ^ R L G A R A V E L L L F G K G O  R C V G I Q  K . Y Q L V G R D t A B
RM-PFX (N) P S A F D R I  L Q S R H O  V I A V H  A L L E O  T P D T P  A C V V  S  L S G S Q  A V R L P L H B
m - F F K  (C) P T P P D R N P A T K M O A K A  H  N  W H  A O  K  I X  1 9  Y  R  N  0  R  I F A  H T P D S  0  C  V  t  O  H  R  X R A  L  V  P 0  P  V T  8 
250 270 200 290
&>FFK-1 A 1 E N H K R P F K O D W L D C A B K H I i  
fiv-FFX a l a h k h t i d q r h y a l s k b l s i *
Jfrt-PFX (HI C V Q V T K D V T K A H D B X R P D E A M X L R G R S F H K N K E V Y K L  _ L A H I R P P A P X  S G 5 Y T V  
RM-PFX (Cl L Q N Q T D F S H R I P X 8 Q W W L K L R P I L K 1 L A K Y B 1 D L D T S E H A H L E K 1 S R X R 5 G B A T V I  
300 310 370
Fig* 4. Alignment of three related PFK sequences. isc-PFK- 
1, Bs-PFK, and the amino (N) and carboxyl (C) halves of RM- 
PFK have been aligned to demonstrate aa sequence 
homologies. A comparison between the aa sequences of Bs- 
PFK and the two halves of RM-PFK was first done by Poorman 
et a l . (1984). The underlined aa are corrections to the
alignment made by Hellinga and Evans (1985). The corrected 
JTc-PFK-1 sequence was obtained by personal communication 
from Philip R. Evans (MRC, Cambridge) while the corrected 
RM-PFK sequence was deduced from the DNA sequence of RM-pf7r 
{Lee et a l M  1987 ).
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Abbreviations: aa, amino acid(s); ADP, adenosine 5'-
diphosphate; ATP, adenosine 5 *-triphosphate; bp, base 
pairs(s); Bs-PFK, Bacillus stearothermophilus PFK; Bs-pfk, 
gene coding for Bs-PFK; DTT, PL-dithiothreitol; EDTA, 
ethylenediaminetetraacetic acid; kb, 1000 bp; LB, Luria 
broth; Mr, molecular weight; nt, nucleotide(s ); PFK, 
6-phosphofructo-l-kinase; pfk, gene coding for PFK; PMSF, 
phenylmethylsulfonyl flouride; RM-PFK, rabbit muscle PFK; 
RM-pfk, gene coding for RM-PFK; SDS, sodium dodecyl 
sulfate.
SUMMARY
The 6-phosphofructo-l-kinase (PFK) gene from Bacillus 
stearothermophilus has been expressed at high-levels in 
Escherichia coli. This expression has been demonstrated by 
complementation studies, SDS-PAGE, and PFK assays of cell 
extracts.. A level of B. stearothermophilus PFK expression 
corresponding to 20% of the total extracted protein was 
calculated from densitometric scans of an SDS- 
polyacrylamide g e l . The high-level of recombinant gene 
expression will enable this laboratory to determine 
structure-function relationships in B, stearothermophilus 
PFK by the method of site-specific mutagenesis.
INTRODUCTION
6-Phosphofructo-1-kinase (PFK; EC 2.7.1.11) catalyzes 
the ATP-dependent phosphorylation of fructose 6-phosphate 
to fructose 1,6-bisphosphate. The activity of this enzyme 
is controlled by physiological modulators and it thus plays 
a key role in the regulation of glycolysis (Uyeda, 1979). 
PFK from B. stearothermophilus {Bs-PFK) and the major PFK 
from E. coli (Fc-PFK-1) share many physical and kinetic 
properties (Evans et a l ., 1981). They are homotetrameric 
enzymes composed of 34-kDa and 35-kDa subunits, 
respectively. Both display cooperative kinetics with 
respect to fructose 6-phos'phate but not with respect to
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ATP, and they are subject to allosteric activation by ADP 
and inhibition by phosphoenolpyruvate. Although the PFK 
isolated from rabbit muscle (RM-PFK) is also composed of 
four identical subunits, each of these 85-kDa subunits is 
more than twice the size of the prokaryotic PFK subunit.
The allosteric regulation of RM-PFK is more complex in that 
it is activated by AMP and fructose bisphosphates, while it 
is inhibited by ATP and citrate.
Poorman et al. (1984) noted internal homology between 
the N- and C-terminal halves of a nearly complete aa 
sequence for RM-PFK. They also discovered homology between 
the aa sequences of Bs-PFK (Kolb et a l ., 1980) and the two 
halves of RM-PFK. This indicated that RM-PFK evolved from 
an ancestor of Bs-PFK by a process of gene duplication and 
divergence. Lee et al. (1987) subsequently obtained a 
genomic clone for RM-PFK and determined the sequence for 
all of the coding exons as well as most of the introns. 
Their deduced aa sequence identified 30-aa residues which 
had been left as a gap in the aa sequence determined by 
Poorman et al. (1984).
Upon sequencing the gene for the major PFK from E. 
coli, Hellinga and Evans (1985) noted significant homology 
between its deduced aa sequence and the sequences for RM- 
PFK and Bs-PFK. However, no homology is evident between 
the deduced aa sequences for the major PFK (Ec-PFK-1) and 
the catalytically distinct minor PFK (Ec-PFK-2) from 
E. coli (Daldal, 1984).
Evans and-co-workers used X-ray crystallography to 
determine the 3-dimensional structures of both the active 
{Evans and Hudson, 1979; Evans et a l . , 1981) and t;he 
inactive conformations (Evans et a l ., 1986) of Bs-PFK. Th 
2.4 X resolution obtained for the active conformation 
provided important details concerning the ligand binding 
sites of the enzyme.
We recently reported the nucleotide (n t ) sequence of 
the PFK gene from B. stearothermophilus (French and Chang, 
1987). We now report the subcloning of the intact Bs-pfk 
gene into the plasmid vector pBR322, the transformation of 
a PFK null E. coli host and the high-level of Bs-PFK 
expression which results. PFK assays of cell extracts 
from this recombinant demonstrate a level of Bs-PFK 
specific activity which is 40-fold higher than found in 
cell extracts from the wild-type B. stearothermophilus.
The high-level of Bs-PFK expression will enable our 
laboratory to use site-specific mutagenesis to investigate 
structure-function relationships in this allosteric enzyme
MATERIALS AND METHODS
(a) Bacterial strains and media
The isolation and characterization of a genomic clone 
for Bs-pfk (gtlO/Bs-pfk) from a \  library of B. 
stearothermophilus DNA has been previously described 
(French and Chang, 1987). The DH5o< competent cells used
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for the primary transformation were obtained from BRL 
(Bethesda, MD). The complementation studies were done 
using DF1020 [a recA derivative of DF1010 (Daldal, 1983): 
pro-82, ApfkB201, recA56, A(rha-pfkA)200, endAl, hsdR17, 
supE44, thi-1] on pfk-selective plates. The DF1020 strain 
was kindly provided by Dr. Barbara Bachmann of the E. coli 
Genetic Stock Center (Yale University School of Medicine, 
New Haven, CN). The pfTr-selective plates were composed of 
minimal medium 6 3 (Cohen and Rickenberg, 1956) supplemented 
with 0.4% mannitol, 80 ;jg/ml proline, 1 pg/ml thiamine 
hydrochloride, and 1.5% (w/v) agar (Hellinga and Evans, 
1985). Strains DF1010 and DF1020 have zero PFK activity 
and do not grow on glucose or mannitol although they will 
grow on glycerol. The DF1010 strain carrying the pFD121 
plasmid (DF1010/pFDl21) was kindly provided by Dr. Dan G. 
Fraenkel of the Harvard Medical School (Boston, M A ) .
Plasmid pFD121 consists of the gene for the minor PFK from 
E. coli (pfkB) cloned between the Hindlll and Pstl sites of 
pBR322 (Daldal, 1983).
(b) Subcloning of Bs-pfk
'The Bs-pfk gene had previously been isolated from a 
phage AgtlO genomic library as a clone designated gtlO/Bs- 
pfk (French and Chang, 1987). Restriction analysis of this 
clone indicated that the EcoRI cloning site was located 
1.2-kb upstream of the Bs-pfk initiation codon. Sequence 
analysis of the Bs-pfk gene identified a Clal site located 
359-nt downstream of the termination codon.
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Double digestions with EcoRI and Clal were performed 
on both gtlO/Bs-pfk and pBR322. The restriction products 
were fractionated on a 1% SeaPlaque agarose gel (FMC 
BioProducts, Rockland, ME). The 2.52-kb EcoRI/Clal 
fragment containing Bs-pfk and the 4.56-kb EcdRI/Clal 
fragment of pBR322 were excised from the gel and ligated 
directly in the low-melting-point agarose (Struhl, 1985). 
The ligation products were used to transform DH5e< competent 
cells (BRL, Bethesda, MD) and plasmid mini-preps were 
performed on two recombinants. Restriction analysis of the 
mini-preps showed that both recombinants contained the 
desired Bs-pfk insert. One of the clones was designated 
pBR322/Bs-pfk and used to transform DF1020.
(c) Transformation of DF1020
The pfk-negative host strain DF1020 was transformed by 
pBR322 and pBR322/Bs-pfk using the frozen storage buffer 
(FSB) method of Hanahan (1983). Ampicillin resistant 
transformants were streaked on LM plates supplemented with 
35 pg/ml ampicillin (Hanahan, 1983) to assure that pure 
clones were obtained. The relatively low transformation 
efficiency of DF1020 (2-4 x 10^ colonies/pg plasmid) may 
explain the failure of previous attempts at the direct 
selection of Bs-pfk.
(d) Complementation of PFK deficiency in DF1020
Four strains were streaked in parallel upon minimal 
media 63 agar plates supplemented with proline, thiamine, 
and mannitol or glycerol: DF1020, DF1020/pBR322,
Fig. 1. Complementation of PFK deficiency in E, coli 
strain DF1020. The following strains were streaked in 
parallel and incubated for 3-days at 37°C upon agar plates 
which were nonselective (Glycerol) or selective (Mannitol) 
for PFK activity (Daldal, 1983). Strains: (1) DF1020, (2)
DF1020/pBR322/fls-pfVf, (3) DF1020/pBR322 , ( 4 ) DF1010/pDFl 2 1 . 
Both DF1010 and DF1020 have zero PFK activity, so only the 
two strains expressing cloned pfk genes (2 & 4) were able 
to grow on the pf/r-selective plates.
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DF1020/pBR322/J9s-p/7r, and DF1010/pFD121 . The photograph in 
Fig. 1 was taken after 3-days of growth at 37°C although 
results were evident after only 2-days. All four strains 
grew on the glycerol plate; however, only those hosts 
containing pfk genes grew on the mannitol plate. This 
experiment provided clear evidence that the Bs-pfk gene 
complements the PFK deficiency in DF1020.
(e) SDS-PAGE of cell lysates and purified Bs-PFK
Overnight cultures of K-10, DF1020, DF1020/pBR322, 
DF1020/pBR322/Bs-p/’A', and B. stearothermophilus strain NCA 
1503 were pelleted by centrifugation, resuspended in 
sonication buffer (50 mM Tris-HCl, pH 7.4, 1 mM DT T , 1 mM 
EDTA, 1 mM PMSF), and lysed by sonication. The total 
protein in each sample was determined with a protein assay 
kit from Bio-Rad Laboratories (Rockville Centre, NY).
Bs-PFK was then purified from the DF1020/pBR322/Bs-p/7f 
lysate using the same procedure followed by Hengartner and 
Harris (1975). This procedure includes the use of an AMP- 
Sepharose 4B affinity column in the final step. The 
protein concentrations after each step of the purification 
scheme were determined using the Bio-Rad protein assay kit. 
Samples of the cell lysates (150 p g) and the purified Bs- 
PFK (15 p g ) were electrophoresed on a 10-15% linear 
gradient SDS/polyacrylamide gel and stained with Coomassie 
blue (Fig. 2).
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Fig. 2. Coomassie-stained SDS-polyacrylamide gel (10-15% 
linear gradient) of cell lysates and purified Bs-PFK. 
Lanes: (1) Mr markers, (2) E. coli K-10, (3) DF1020, (4)
DF1020/pBR322, (5) DF1020/pBR322/Bs-pf/r, (6) purified Bs-
PF K , (7) B. stearothermophilus NCA 1503. The single most 
abundant protein in lane (5) co-migrates with purified Bs- 
PFK and has a Mr of 34 kDa.
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(f) PFK activities of cell lysates and purified Bs-PFK
The PFK activities of each cell lysate and the 
purified Bs-PFK were assayed by the method of Kotlar^ and 
Buc (1982). This method was used by Hellinga and Evans
(1985) to assay their recombinant Ec-PFK-l. However, this 
assay differs significantly from the one used by Hengartner 
and Harris (1975) to determine the specific activity of 
authentic Bs-PFK. Table 1 summarizes the results of these
assays. The recombinant Bs-PFK which was purified to near
homogeneity as judged by SDS-PAGE was found to have a
specific activity of 140 U/mg.
RESULTS AND DISCUSSION
The results of complementation studies and assays for 
PFK activity indicate that plasmid pBR322/Bs-pfk directs 
the production of active Bs-PFK in an E. coli host. SDS- 
PAGE of cell lysates demonstrate that the single most 
abundant protein produced by this recombinant has a Mr 
equivalent to that of JBs-PFK. Densitometric scans indicate 
that Bs-PFK represents 20% of the total protein extracted 
from cell lysates of the recombinant. The activity of the 
enzyme in these cell lysates is demonstrated by assays 
showing a level of Bs-PFK specific activity which is 40 
times greater than that found in cell lysates of wild-type 
B. stearothermophilus.
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TABLE I
PFK expression in various strains and recombinants*
Cell lysate 
or preparation
PFK 
volume 
activity 
(U/ml)
[Protein] 
(mg/ml)
PFK
specific
activity
(U/mg)
E. coli K-10 1.5 7 .51 0.2
E. coli DF1020 0.0 7.49 0.0
DF1020/pBR322 0 . 0 9.90 0.0
DF1020/pBR322/Bs-pf/f 463.7 9.21 50.3
Purified Bs-PFK 96 .8 0.69 140.3
B. stearo. NCA 1503 5 . 2 4.36 1 . 2
* Assays were carried out as described .in Materials and 
Methods, section (f). The K-10 strain of E, coli is the 
wild-type from which DF1020 was derived (Daldal, 1983).
The construction of pBR322/Bs-pfk is described in section
(b) and the transformation of DF1020 is described in 
section' (c) of Materials and Methods. The purification of 
Bs-PFK from the DF1020/pBR322/Bs-p/7r cell lysate is 
described in section (e) of Materials and Methods. NCA 
]503 is the strain of B. stearothermophilus which was used 
by Evans and Hudson (1979) for the crystal structures of 
Bs-PFK and by French and Chang (1987) for cloning the 
Bs-pfk gene.
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Two lines of evidence suggest that this high level of 
expression is directed from the endogenous Bs-pfk promoter. 
First, the tyrosyl-tRNA synthetase gene from B. stearo­
thermophilus was expressed at levels representing 10% of
>
total soluble protein when it was cloned into the same 
pBR322 vector (Barker, 1982). Second, the region 
immediately upstream of the Bs-pfk coding sequence contains 
elements which share limited homology with E. coli 
consensus sequences for transcriptional initiation and 
ribosome binding. These homologies are detailed in Fig. 3.
The high-level expression of Bs-PFK in E. coli will 
enable this laboratory to use site-specific mutagenesis to 
probe the structure-function relationships in this 
allosteric enzyme. The crystal structures corresponding to 
the R-state (Evans and Hudson, 1979) and the T-state (Evans 
et a l . , 1986) of the enzyme have already been determined. 
The aa residues which are critical to the function of the 
enzyme have therefore been identified (Hellinga and Evans, 
1985). This wealth of structural data makes it possible to 
design site-specific mutations for the independent 
verification of the active and allosteric sites (Zoller and 
Smith, 1985).
Site-specific mutations are also planned to help 
characterize the transition of the enzyme between the 
active R-state and the inactive T-state (Blangy et a l ., 
1968). The 44% aa sequence homology (Poorman et a l ., 1984) 
and the conservation of critical aa residues (Hellinga and
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70 80 90 100 110
Bs-pfk TGGTACATTAAAGTTGTTCAAGAGCGACAGATGTATGAGGTCGGACGTGT
** * *** *
Ec-con TTGACa<--------20bp-------- >TAtAaT ++ +
120 130 140 150 160
Bs-pfk TGAATTTGATACAAATGAGGTGAAATGAGTGAAACGCATTGGTGTGTTGA
Bs-PFK *** * METLysArglleGlyValLeuT
Ec-con AGGAGG<5bp>
Fig. 3. Homologies between the Bs-pfk promoter region and 
E. coli consensus sequences for transcriptional initiation 
and ribosome binding {Ec-con). The 5 ’-flanking region of 
the Bs-pfk gene is shown at top with homologous E. coli 
consensus sequences (Lewin, 1985) aligned beneath it. The 
matches between the two are marked with asterisks. The 
numbering of the Bs-pfk gene is the same as that in a 
previous paper (French and Chang, 1987). Transcription of 
the Bs-pfk gene probably initiates at one or more of the 
positions marked with plus sign. Translation of the gene 
begins with the GTG initiation codon 5-bp downstream of the 
Shine-Dalgarno sequence.
Evans, 1985) between Bs-PFK and N-terminal half of RM-PFK 
suggest that structure-function relationships found in 
fls-PFK may well apply to the more complex RM-PFK. The PFK 
from B. stearothermophilus therefore promises to be an 
excellent system in which to study the structure-function 
relationships determining the allosteric nature of enzymes.
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Abbreviations: a a , amino acid(s); A D P , adenosine 5 ’-
diphosphate; ATP, adenosine 5 *-triphosphate; bp, base 
pairs(s); Bs-PFK, Bacillus stearothermophilus PFK; C, 
cytidine; d, deoxyribo; Fc-PFK-1, the major Escherichia 
coli PFK; EtBr, ethidium bromide; G, guanosine; kb, 1000 
bp; nt, nucleotide(s ); PFK, 6-phosphofructo-l-kinase; RM- 
PFK, rabbit muscle PFK; RM-pfk, the gene for RM-PFK; SDS, 
sodium dodecyl sulfate; SSC, 0.15 M NaCl, 0.015 M Naj• 
citrate, pH 7-8; T, thymidine.
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SUMMARY
A partial cDNA for rabbit muscle 6-phosphofructo-l- 
kinase (RM-PFK) has been cloned and sequenced. The 
nucleotide (nt) sequence of the cDNA agrees with the 
previously determined RM-pfk genomic sequence. In 
addition, the amino acid (aa) sequence deduced from the 
cDNA is nearly identical to the RM-PFK sequence previously 
determined by peptide analysis. A significant degree of 
homology exists when the aa sequence of RM-PFK is compared 
with the sequences of Bacillus stearothermophilus PFK or 
Escherichia coli PFK-1. The cloning and sequencing of the 
RM-PFK cDNA fragment represents significant progress toward 
the long-term goal of using site-specific mutagenesis to 
investigate the structure-function relationships in this 
allosteric enzyme.
INTRODUCTION
6-Phosphofructo-l-kinase (PFK; EC 2.7.1.11) catalyzes 
the ATP-dependent phosphorylation of fructose 6-phosphate 
to fructose 1,6-bisphosphate. The activity of this enzyme 
is controlled by physiological modulators and it thus plays 
a key role in the regulation of glycolysis (Uyeda, 1979). 
PFK from B. stearothermophilus (Bs-PFK) and the major PFK 
from E. coli {Ec-PFK-1) share many physical and kinetic 
properties (Evans et a l ., 1981). They are homotetrameric
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enzymes composed of 34-kDa and 35-kDa subunits, 
respectively. Both display cooperative kinetics with 
respect to fructose 6-phosphate but not with respect to 
ATP, and they are subject to allosteric activation by ADP 
and inhibition by phosphoenolpyruvate. Although the PFK 
isolated from rabbit muscle (RM-PFK) is also composed of 
four identical subunits, each of these 85-kDa subunits is 
more than twice the size of the prokaryotic PFK subunit.
The increased size of RM-PFK reflects the complexity of its 
allosteric regulation. In addition to responding to the 
same effectors which modulate the prokaryotic PFK’s, RM-PFK 
is activated by AMP and fructose bisphosphates and it is 
inhibited by ATP and citrate.
Poorman et a l . ( 1984) noted internal homology between 
the N- and C-terminal halves of a nearly complete aa 
sequence for RM-PFK. They also discovered homology between 
the aa sequences of Bs-PFK (Kolb et a l ., 1980) and the two 
halves of RM-PFK. This indicated that RM-PFK evolved from 
an ancestor of Bs-PFK by a process of gene duplication and 
divergence. Upon sequencing the gene for the major PFK 
from E. coli, Hellinga and Evans (1985) noted significant 
homology between the deduced aa sequence and the sequences 
for RM-PFK and Bs-PFK.
Lee et a l . (1987) obtained a genomic clone for RM-PFK 
and determined the sequence for all of the coding exons as 
well as most of the introns. Their deduced aa sequence 
identified 30-aa residues which had been left as a gap in
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the aa sequence determined by Poorman et a l , (1984). In 
addition, French and Chang (1987) cloned and sequenced the 
gene encoding Bs-PFK. This sequence served to correct 
errors present in previously published versions of the Bs~
PFK aa sequence (Kolb et a l ., 1980, Poorman et a l ., 1984, 
Hellinga and Evans, 1985). The aa sequence alignment of 
RM-PFK, Bs-PFK, and Ec-PFK-1 made by French and Chang 
(1987) is therefore the most correct version to date.
This paper describes the cloning and sequencing of a 
partial cDNA for RM-PFK. The cDNA library was prepared 
from rabbit muscle polyadenylated RNA by the method of 
Okayama and Berg (1982). A 250-nt cDNA probe for RM-PFK 
was obtained from Scott Putney (Repligen, Boston, MA) and 
used to isolate a positive clone from the library by colony 
hybridization. Sequence analysis of this positive clone 
showed that it contained one-quarter of the RM-PFK coding 
sequence and the 3 ’-untranslated region of RM-PFK mRNA.
The cDNA sequence confirms one-quarter of the RM-PFK aa 
sequence determined by Poorman et a l . (1984) and thus 
verifies the homologies between RM-PFK and the two 
prokaryotic PF K ’s .
MATERIALS AND METHODS
(a) Bacterial strains, media, and methods
The 3 ’-oligo(dT)-tailed pSV7186-derived plasmid primer 
and the 3 *-oligo(d G )-tailed pSV1932-derived Hindlll linker
64
required for cloning cDNA by the method of Okayama and Berg
(1982) were obtained from P-L Biochemicals, Division of 
Pharmacia, Inc. (Milwaukee, W I ). The E. coli host strain 
DH1 was obtained from the American Type Culture Collection, 
Rockville, MD (ATCC no. 33849) and grown in SOB media 
(Hanahan, 1983). The M13mpl8 and M13mpl9 vectors as well 
as the JM107 and JM109 hosts were obtained from Joachim 
Messing, presently at Rutgers University (Piscataway, NJ). 
The DH5<* competent cells used for transient transformation 
by the M13 phage recombinants were obtained from BRL 
(Bethesda, M D ) . The following methods were performed as 
described by Maniatis et a l . (1982) unless otherwise 
specified.
(b) Preparation of a probe for RM-PFK
A 250-nt cDNA probe for RM-PFK was kindly provided by 
Scott Putney, presently at Repligen (Boston, M A ). Dr. 
Putney had isolated the cDNA probe from a shotgun cDNA 
library of rabbit muscle polyadenylated RNA cloned into the 
phage vector M13mp8. Among the 178 randomly selected M13 
recombinants whose sequences were determined (Putney et 
a l . , 1983 ), a computer search for RM-PFK coding regions 
identified a single RM-PFK clone. The sequence of the cDNA 
insert in this clone encoded 60-aa in the C-terminal region 
of RM-PFK (Poorman et al. 1984).
The replicative form of the M13 clone was amplified 
and the DNA restricted with BamUl and Hindlll to release 
the RM-PFK cDNA insert. The restriction digest was treated
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with bacterial alkaline phosphatase, fractionated on a 1% 
agarose gel, and the 250-bp cDNA insert purified by 
electroelution. The dephosphorylated RM-PFK cDNA insert
was kinased with [#- 32p]^TP and end-filled with [o<- 32p]dATP
» A
to a specific activity of 1x10° cpm/^ig for screening the
cDNA library.
(c) Construction of cDNA library
Polyadenylated RNA was isolated from rabbit muscle by 
the method of Chirgwin et al. (1979) and used to construct 
a cDNA library by the method of Okayama and Berg (1982).
The following methods represent the only deviations from 
the published protocols.
(i) Oligodeoxycytidylate [oligo(dC)] addition: The
second step of the Okayama-Berg procedure calls for a 5 min 
addition of oligo(dC) tails by terminal deoxynucleotidyl 
transferase. However, the rate of the terminal transferase 
reaction is dependent upon many variables including the 
concentration of 3 ’-ends in the reaction mixture (Deng and 
W u , 1981). This concentration is difficult to accurately 
determine during the synthesis of cDNA, so the optimal 
reaction time for the tailing reaction was determined 
empirically (Affolter and Anderson, 1985). Aliquots of the 
tailing reaction were removed at time intervals, terminated 
by phenol extraction, and used for the remainder of the 
Okayama-Berg procedure. The transformation efficiencies 
obtained from each sample were compared and plasmid mini- 
preps of random clones were assayed for cDNA content by
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electrophoresis on agarose gels. This procedure determined 
that a terminal transferase reaction time of 2.3 rain was 
optimum for this particular preparation of cDNA.
(ii) Transformation of E. coli: Okayama and Berg
transformed host strain HB101 with their cDNA libraries 
using minor modifications of the procedure described by 
Cohen et al. (1972). This procedure typically yields 1x10^ 
transformants per i^g of supercoiled plasmid pBR322.
However, the transformation procedure for strain DH1 
described by Hanahan (1983) is about ten times more 
efficient. The Hanahan method was therefore used to 
transform strain DH1 with the rabbit muscle cDNA library, 
d) Colony hybridization of cDNA library
Host cells made competent by the method of Hanahan
(1983) were transformed by the rabbit muscle cDNA library 
and plated onto BA85 nitrocellulose filters (Schleicher & 
Schuell, Keene, N H ) at a density of 10,000 colonies per 
82 mm filter. Two replica filters were made from each of 
four master filters. The replicas were incubated for 5 hrs 
on L plates containing 100 jug/ml ampicillin and transferred 
to L plates containing 250 ^ig/ml chloramphenicol for 
incubation overnight.
The lysis, prehybridization, hybridization, and 
washing of the filters were done as per Maniatis et a l .
(1982) with only one minor addition to the prehybridization 
protocol. After an initial prehybridization of 2 hrs at 
42°C, the filters were each placed colony side up in a
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shallow tray of prehybridization solution and rubbed gently 
with a gloved finger (Hanahan and Meselson, 1983). This 
treatment assured the removal of colony debris and thus 
eliminated the background signals which would have 
otherwise been present after hybridization.
The hybridization was performed using the ^p_jLabe 1 eel 
250-nt cDNA probe at a specific activity of 1x10® cpm//Jg 
and a final concentration of 1.3x10® cpm/ml in the 
hybridization solution. The most stringent wash of the 
filters was at 68°C for 2 hrs in Ix SSC / 0.1% SDS. An 
overnight exposure revealed two strong signals on each of 
two duplicate filters. However, only one positive clone 
could be isolated after re-screening the colonies 
corresponding to the two signals. The single positive 
clone was designated pOB220/RM-p/lr and analyzed as follows, 
e} Southern analysis
Southern blot analysis was used to determine the 
maximum length of the cDNA insert in pOB220/RM-pfA'. The 
cloned DNA was isolated by the plasmid mini-prep procedure, 
restricted, and fractionated on a 1% agarose gel. The DNA 
fragments were bidirectionally transferred to 
nitrocellulose and probed with kinased oligonucleotides 
corresponding to known positions in the RM-PFK coding 
region. The Southern blots shown in Fig. 1 suggested that 
the cDNA clone encoded no fewer than 96-aa and no more than 
267-aa.
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Fig. 1. Southern blots of pOB220/RM-p/A'. Panel A: EtBr
stained 1% agarose gel. Lanes: (1 & 7) 300 ng of X  phage
DNA cut by Hindlll; (2-5) 400 ng of pOB2 20/RM-pfA' cut by;
(2) no enzyme, (3) Pstl, (4) PvuII, (5) PstI + PvuII; (6)
1 pg of V P F K - 1  (Lee et a l ., 19 87) cut by EcoRl. Panel B: 
Southern blot of agarose gel probed with 32p_^abeieci pp^ 6 
oligonucleotide complementary to codons 684-688. Panel C: 
Southern blot of agarose gel probed with "P-labeled PFK 5 
oligonucleotide corresponding to codons 513-517. The 
hybridization of pOB220/RM-pf7r with PFK 6 but not with PFK 
5 indicates that the 5 ’-end of the PFK cDNA lies between 
codons 518 and 684 of the RM-pf7r gene.
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f) Restriction analysis
Restriction analysis of pOB220/RM-pfk was performed by 
standard procedure. Single and double restriction 
digestions were made of the plasmid DNA and resulting 
fragments were fractionated on agarose gels. Restriction 
mapping was facilitated by detailed knowledge of the 
plasmid vector (Okayama and Berg, 1982) as well as the RM- 
PFK coding sequence (Lee et a l ., 1987). A restriction map 
of the partial RM-PFK cDNA is shown in Fig. 2.
g) Sequence analysis
The restriction map of pOB220/RM-pf7r revealed that the 
entire cDNA insert could be directionally excised from the 
Okayama-Berg vector by the restriction endonucleases 
Hindlll and PvuII. This fragment was subcloned between the 
Hindlll and SmaI sites of the phage vector M13mpl9 after 
making the appropriate restrictions and fractionating the 
products on a 1% Sea-Plaque agarose gel (FMC BioProducts, 
Rockland, ME). The desired vector and insert bands were 
excised from the gel and ligated directly in agarose using 
the procedure of Struhl (1985).
Competent DH5* cells obtained from BRL (Bethesda, MD) 
were used as transient hosts for the transformation. The 
transformation was plated with JM109 lawn cells in order to 
support the growth of recombinant phage. Template DNA was 
prepared from white plaques as described by Messing (1983). 
The PFK 6 oligonucleotide complementary to codons 684-688 
of RM-pf7f was then used to prime DNA sequencing reactions
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Fig. 2. Sequencing strategy for RM-PFK cDNA. The sequence 
shown in Fig. 3 is represented as a bold line with selected 
restriction sites and locations. The first C of the 
oligo(dG)-tailed PstI site is defined as position 1 in both 
Figures 2 and 3. The arrow above the restriction map 
indicates the location and orientation of RM-pfVf codons 
598-781. The arrows below the restriction map indicate the 
location and direction in which the sequence data was read. 
The dideoxy chain termination method of Sanger et a l .
(1977) as modified by Biggin et a l . (1983) for [35s)dATP
was used to sequence subclones in M13mpl8 and M13mpl9
r
(Norrander et al.t 1983). In addition to the M13 universal 
primer, two other oligodeoxynucleotides were made on an 
Applied Biosystems Model 380A DNA Synthesizer for use as 
sequencing primers. The sequence of the PFK 6 
oligonucleotide is complementary to RM-pP7f codons 684-688 
while the sequence of PFK 7 corresponds to codons 767-772.
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using the dideoxy chain termination method (Sanger et a l ., 
1977). The resulting sequence verified the identity of the 
partial RM-PFK cDNA clone and indicated that it had a 5 ’- 
end corresponding to .codon 598 of RH-pfk. Additional M13 
clones were generated and sequenced in a similar manner. A 
summary of the sequencing strategy for the cDNA insert in 
pOB220/RM-pfA- is shown in Fig. 2 and the completed sequence 
is presented in Fig. 3.
RESULTS AND DISCUSSION
The 549-nt coding sequence for RM-PFK contained in 
pOB220/RM-p/7i predicts an aa sequence which is identical to 
the corresponding portion of the RM-PFK sequence published 
by Poorman et a l . (1984). In addition, the nucleotide
sequence of the cDNA is in agreement with the RM-p/7f 
genomic sequence determined by Lee et al. (1987). These
identities confirm that pOB220/RM-pfk contains a partial 
cDNA for RM-PFK. This cDNA is particularly valuable in 
that it defines the polyadenylation site of RM-p/lr mRNA.
The genomic clone obtained by Lee et al, (1987) extended 
only 151-nt downstream of the termination codon and was 
therefore uninformative in this regard. A polyadenylation 
signal of AATTAA is located 607-nt downstream of the 
termination codon and 23-nt upstream of the poly-A tail in 
the RM-PFK cDNA clone.
CTGCAGGGGGGGGGGGGGGAGCXXTTCACCATCCGAGACCrGCAGGCGAATGTTGAACACCTGGTG
GluProPheThrlleArgAspLeuGlnAlaAsnValGliiHisLeuVal
CAAAAGATGAAGACGACTGTGAAGAGAGGCTrcGTGCTGAGGAACGAGAAGTGCAATGAGAATTAC
GlnLysMetLysThrThrValLysArgGlyLeuValLeuArgAsnGluLysCysAsnGluAsnTyr
ACCACGGACTTCATCnTCAACCTGTACTCTGAGGAGGGGAAGGGCATCrrrCXlACAGCAGGAAGAAC
ThrThrAspPhellePheAsnLeuTyrSerGluGluGlyLysGlyllePheAspSerArgLysAsn
GTGCTTGGCCACATGCAGCAGGGCGGGAGCCCCACTCCCTTrGACAGGAACTTTGCTACTAAGATG
ValLeuGlyHisMetGlnGXnGlyGlySerProThrProPheAspArgAsnPheAlaThrLysMet
GGAGCCAAGG(XATGAACriXXiATGGCrGGGAAGATCAAGGAGAGTTACXXjTAACGGGOGGATCTrC
GlyAlaLysAlaMetAsnTrpMetAlaGlyLysIleLysGluSerTyrArgAsnGlyArgllePhe
CHXAACACHXTGACTCHjGCTCrnnTCriXXKjAATGCGTAAGAGGGGICTGGTCTTCCAACCAGTG
AlaAsnThrProAspSerGlyCysValLeuGlyMetArgLysArgAlaLeuValPheGlnProVal
ACTGAGCTGCAGAATCAGACGGACTITGAGCACCGAATCCCCAAGGAACAGTGGTGGCTGAAGCrG
ThrGluLeuGlnAsnGlnThrAspPheGluHisArglleProLysGluGlnTrpTrpLeuLysLeu
CGGCCCATCCTCAAAATCCTAGCCAAGTACGAGA'ITGACTrGGACACCTCCGAGCACGCGCATCTG 
ArgProIleLeuLysIleLeuAlaLysTyrGluI1eAspLeuAspThrSerGluHisAlaHisLeu
GAGCACATCIXXCGAAAACnjTCTGGGGAAGCCACCGTCTAAGCXTrCGGAGCGAGGGACAGGCTGT 
GluHisiXeSerArgLysArgSerGlyGluAlaThrVal *
CrGATCACATCAAAGATGCACGCCGTGTCCATGTCGTAGCTCTTTAGTCATTAGGGTCCCTGTACT 
TGTGCACCCAAGGCCGTGACCAGCTCTGGCCGGGAACCGGGAGCATGCAGTAGGTGGAAGCTCCTG 
TAGTAGACnXXXJTCATGACCCXjCACCCCAGCCTGGTCTGTTACACAGGCAGGGTCCTGTAGTGCTC 
CrGOTGGACCACACAGGTAGAACrcCCTTTACACGCGCTTTATTTATTTCTTTGTGTTAACAAGAG 
TGTCGGCTTCrrCACACTCCrrGCTGCAGTGACGACTCTGACTACACAATAACGCACTGCATGCATCT 
GCTCTGCTGTGCTCTCTCiCCTGCAGACTACGAGCAGCTTGGCGTCCGTACTCTTCCTAGGGCAAAG 
GCCTTTGCACCTTAAGCGGCGiraXGTOnTlTCCTGCAGCCCTTGGCCCITTTCGGCCCCCCCG 
GGCCCCTITTAAAAGGGGTTTGGGGGGGGTTTTCCCCAATTCTCCCCTTTTCCGGG'nTAAATGGG 
GCCCGCCCTITCCGTrAAAAAACCCCTITAAAATTGCCCTGGGGGGCCGGGGGCAAATTAAAATTTr 
AACAAGCCAACCCCCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
A.AAAAGTA(XTTCTGAGGCGGAAAGAACCAGCrrG 1288
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132
198
264
330
396
462
528
594
660
726
792
858
924
990
1056
1122
1188
1254
Fig. 3. Nucleotide and deduced amino acid sequences of RM-PFK cDNA. 
The first C of the oligo{dG)-tailed PstI site is defined as position 1.
The partial cDNA clone for rabbit muscle PFK 
represents significant progress toward the long-term goal 
of using site-specific mutagenesis to investigate the 
structure-function relationships in this allosteric enzyme. 
In cases where full-length cDNA’s are difficult to obtain 
directly, it has been necessary to splice partial cDNA’s 
and genomic fragments together in order to construct a 
full-length clone (Toole et a l ., 1984). Alternatively, 
oligonucleotide-directed mutagenesis has been used to 
delete introns from genomic clones (Wallace et a l ., 1980).
It may prove necessary to pursue one of these 
experimental designs in order to obtain a full-length PFK 
cDNA. In either case, pOB220/RM-pf7r represents a 
significant contribution since it contains one-quarter of 
the RM-PFK coding sequence. The corresponding region of 
the genomic clone contains 5 of the 22 known introns.
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SUMMARY
The first two sections of this dissertation describe 
the development of a system for determining the 
relationships between structure and function in the PFK 
from Bacillus stearothermophilus (Bs-PFK). This system for 
site-specific mutagenesis was developed by cloning the gene 
encoding Bs-PFK, determining the nucleotide sequence of the 
gene, and directing the expression of Bs-PFK in a PFK null 
strain of Escherichia coli. Part I of the Appendix 
addresses the experimental design and significance of 
future Bs-PFK research.
The cloning and sequencing of a partial cDNA for 
rabbit muscle PFK are the subjects of the third section of 
this dissertation. The cloned cDNA covers one-quarter of 
the RM-PFK coding sequence starting from the 3 ’-end of the 
gene. The significance of this work with respect to the 
long-term goal of using site-specific mutagenesis to 
determine structure-function relationships in RM-PFK is 
addressed Part II of the Appendix.
In summary, the work presented here represents 
significant progress toward using the techniques of 
molecular biology to enhance our understanding of the 
relationships between structure and function in the key 
regulatory enzyme of the glycolytic pathway.
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APPENDIX
Experimental Design and Significance of Future Research
I . Research on Bs-PFK
A. Immediate Goals
The isolation, purification and enzymatic analysis of 
Bs-PFK are projects which should be undertaken in the near 
future. This work is important because a rigorous 
assessment of Bs-PFK allosteric behavior has never been 
published. The enzymatic analysis is now feasible due to 
the high level of Bs-PFK produced by the recombinant 
DF1020/pBR322/Bs-PFK. The present level of Bs-PFK 
expression corresponding to 20% of the total soluble 
protein is more than adequate for large-scale Bs-PFK 
purification. However, the yield of Bs-PFK can be 
improved by the following lines of investigation.
The yield of Bs-PFK per liter of culture can most 
easily be increased by improving the nutritional quality of 
the culture medium. It is estimated that this yield can be 
improved several-fold simply by growing the cell cultures 
in TB rather than LB media (Tartof and Hobbs, 1987).
The production of Bs-PFK in cell cultures of 
DF1020/pBR322/Bs-pf*A' can be optimized by assaying PFK 
activity at various points on the growth curve. Four 
preliminary PFK assays of cell lysates from mid-log, 
late-log, mid-stationary and late-stationary phases of cell
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growth will indicate the culture phase at which the ratio 
of active PFK to cell mass is greatest. One would expect 
cell death and the resulting protease activity to reduce 
this ratio at some point on the growth curve. There is 
also a small possibility that Bs-PFK might be released from 
the bacterial cells, so PFK assays should be performed on 
the culture supernatants as well as the cell pellets.
There are also a number of relatively simple genetic 
manipulations which should increase production of Bs-PFK. 
The first class of such manipulations involves the insert 
fragment carrying the Bs-pfk gene. Hellinga and Evans
(1985) found that the level of Bc-PFK-1 expression could be 
increased nearly four-fold by simply deleting 1.5 kb of 
extraneous DNA flanking the 5'-end of the Ec-pfkA gene.
The construction pBR322/Bs-pfk contains at least 1 kb of 
5 '-flanking sequences which can presumably be deleted.
A second class of genetic manipulations involves the 
vector carrying the Bs-pfk gene. Vector copy number plays 
a major role in the level of Bs-PFK expression. The pBR322 
vector which carries the Bs-pfk gene has a copy number of 
about 20 plasmids per bacterial cell. Reducing the size of 
this vector has been shown to increase the copy number by
1.5- to 3-fold (Maniatis et al., 1982). Subcloning the 
2.52 kb BcoRI / Bind III fragment containing Bs-pfk from 
pBR322/Bs-pf7r into the corresponding sites of pUC18 or 
pUC19 may therefore lead to a substantial increase in 
Bs-PFK expression.
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The single-stranded bacteriophage vector Ml3mpl8 has a 
copy number of approximately 200 phage genomes per cell. A 
recombinant bacteriophage designated mpl8/Bs-pfk has 
already been constructed by a subcloning procedure 
analogous to the one which created pBR322/Bs-pf7r. Time- 
course PFK assays should be performed on JM107 cell 
cultures which have been infected by this recombinant.
If m p 18/Bs-pfk directs a high level of Bs-PFK expression, 
one might consider creating a PFK null M13 host strain by 
transfering the F ’ episome from JM107 into DF1020. This 
line of investigation is quite attractive since it may be 
possible to use the same M13 construction for site-specific 
mutagenesis and expression of mutant Bs-PFK.
The development of alternative host strains belongs to 
a third class of genetic manipulations which might lead to 
an increase in Bs-PFK production. There is a small 
possibility that E. cold protease activity may be 
limiting the production of Bs-PFK by DF1020. If evidence 
supporting this possibility develops, it may prove 
worthwhile to express Bs-PFK in a lon~ strain of E. cold 
such as Y1088 (Huynh et a l ., 1985). A significantly higher 
level of Bs-PFK production in the absence of Ion protease 
would make crossing the Ion deletion into DF1020 desirable.
B. Site-specific Mutagenesis of Bs-PFK
The cloning and high-level expression of the Bs-pfk 
gene has made it possible to determine the structure- 
function relationships of the allosteric enzyme using site-
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specific mutagenesis. The method of choice for making 
predetermined point mutations in a cloned gene is 
oligonucleotide-directed mutagenesis (Zoller and Smith, 
1983) .
This procedure uses in vitro enzymatic reactions to 
incorporate an oligonucleotide containing the desired base 
change(s) into a cloned gene. The classical approach 
involves subcloning the gene of interest into bacteriophage 
M13 and purifiying single-stranded recombinant phage DNA.
An oligonucleotide containing the desired mismatch{es) is 
then annealed to the gene and extended with the Klenow 
fragment of DNA polymerase I. The nicks in the resulting 
double strands of DNA are sealed with DNA ligase and the 
products of the ligation are used to transform an E. coli 
host.
The yield of mutant phage is often very low, but 
techniques for screening and selecting mutant phage have 
been developed. One of these techniques involves 
generating the single-stranded DNA substrate in dut~ ung~ 
mutants of E. coli (Kunkel, 1985). The resulting phage DNA 
will therefore contain a significant number of uracil 
substitutions for thymine. After annealing and extending 
the oligonucleotide, the duplex of DNA used for 
transformation will have uracil incorporated in the wild- 
type strand but the synthetic strand containing the 
mismatched oligonucleotide will be normal in constitution. 
The wild-type strand will therefore be degraded by uracil-
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N-glycosylase after transformation of an ung+ E. coli host, 
while the strand containing the mutation will replicate and 
produce progeny phage.
This technique will produce a site-specific mutation 
frequency approaching 100% (Kunkel, 1985). Progeny phage 
can always be screened for the desired mutation by 
hybridization with the original ^P-labeled oligonucleotide 
containing the mismatch. However, with a high mutation 
frequency it is more convenient to sequence the regions of 
interest from several recombinants. Once a mutant clone is 
identified, it is prudent to sequence the entire gene since 
other mutations may have been introduced during the in 
vitro manipulations.
Plans have been formulated to perform oligonucleotide- 
directed mutagenesis on the Bs-pfk gene using the 
techniques described above . The construction mpl8/Bs-pfA 
consists of the entire Bs-pfk gene subcloned into the 
single-stranded phage vector M13mpl8. A dut~ ung~ strain 
of E. coli will be infected by this recombinant and uracil- 
containing single-stranded DNA purified from the progeny 
phage. The protocol described above will then be performed 
using four different mutagenic oligonucleotides.
The mutant Bs-pfk genes which result may well direct 
adequate levels of Bs-PFK expression from the M13 vectors.
If this is not the case, the 2.52 kb EcoRl / i/indlll 
fragments containing the mutant Bs-pfk genes will have to 
be subcloned into the corresponding sites of pBR322.
Once a suitable level of expression is obtained, the 
kinetics of each of the four mutant Bs-PFK’s will be 
compared with those of the cloned wild-type Bs-PFK.
Similar kinetic constants will indicate that the amino aci 
substitution had little effect on the function of the 
enzyme. This in turn will argue that the mutated amino 
acid was not critical to catalytic or allosteric function. 
However, a difference in kinetic constants between the 
standard and experimental Bs-PFK's will indicate that the 
mutated amino acid played a critical role in the function 
of the enzyme. Furthermore, the nature of the difference 
in kinetic constants will yield valuable information 
concerning the function of the amino acid under study.
Four preliminary mutations of Bs-PFK have been chosen 
which will enhance our understanding of this allosteric 
enzyme. The first three mutations will verify the 
locations of the three ligand-binding sites in Bs-PFK whil 
the fourth will probe the conformational transition of the 
enzyme between the active R-state and the less active 
T-state.
The immediate goal will be to verify the positions of 
the three ligand binding sites which have been identified 
from the crystal structures of Bs-PFK. There is little 
doubt that these binding sites are correct, but 
oligonucleotide-directed mutagenesis will confirm that the 
ligand-binding behavior of the enzyme in solution is the 
same as its behavior in the crystalline state. The
97
following three mutations were designed to alter the 
kinetics of the enzyme without perturbing the tertiary 
structure or destroying catalytic activity. These 
mutations also involve amino acids which are absolutely 
conserved among Bs-PFK, Ec-PFK-1, and the catalytic 
N-terminal half of RM-PFK.
The nature of the fructose 6-phosph.ate binding site 
will be verified by substituting an Ala for Glu-222. This 
mutation amounts to the loss of the methylene carboxylic 
acid group which is responsible for hydrogen-bonding the 04 
of fructose 6-phosphate. The mutation should decrease the 
affinity of the enzyme for fructose 6-phosphate and thus 
reduce the enzymatic activity of Bs-PFK.
The ATP binding site will be verified by substituting 
a Cys for Ser-9. This Ser contacts the ribose of ATP, so 
changing the hydroxyl group of Ser-9 to a sulfhydryl group 
should cause a subtle change in the Km of the enzyme for 
ATP. While it is difficult to predict the result of this 
change in geometry and decrease in hydrogen-bonding 
capacity, the mutation should produce a detectable change 
in the kinetics of the mutant enzyme.
The location of the effector site will be verified by 
substituting an Ala for Arg-25. The crystallographic 
evidence indicates that both the activator ADP and the 
inhibitor phosphoenolpyruvate bind to this effector site. 
The Arg-25 hydrogen bonds the alpha- and beta-phosphates of 
ADP, so removing the ethylene guanidinium group will
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decrease the affinity of the enzyme for the activator ADP. 
The resulting enzyme should therefore require higher 
concentrations of ADP than the wild-type enzyme to achieve 
the same level of activation.
When studied at a resolution of 6 X, the phosphate 
group of the inhibitor phosphoenolpyruvate appears to bind 
in the same place as the beta-phosphate group of ADP. The 
Arg-25 to Ala mutant should therefore require higher 
concentrations of phosphoenolpyruvate than the wild-type 
enzyme to achieve the same level of inhibition. The 
phosphate group of phosphoenolpyruvate is also hydrogen- 
bonded by Arg-21, so a decrease rather than a total loss of 
inhibition by phosphoenolpyruvate is expected.
Oligonucleotide-directed mutagenesis will also be used 
to investigate the allosteric transition of J5s-PFK between 
the active R-state and the less active T-state. Evans et 
a l . (1981) suggest that this transition involves "the 
rearrangement of essentially rigid subunits into a new 
quaternary structure. The binding sites for the substrate 
fructose 6-phosphate and the allosteric effectors ADP and 
phosphoenolpyruvate then crosslink the subunits, locking 
the structure into the preferred conformation.1’
Sufficient information is already available to 
construct a mutant enzyme which will favor the less active 
T-state. The Arg-252 residue of the fructose 6-phosphate 
binding site not only hydrogen bonds the P 6 , 02, and 05 of 
this substrate, but it is also central to a network of
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hydrogen bonds linking fructose 6-phosphate to'the adjacent 
subunit. The loss of the ethylene guanidinium group will 
not only reduce the enzyme's affinity for fructose 6- 
phosphate, but it will also interfere with the change in 
conformation to the more active R-state brought about by 
the binding of fructose 6-phosphate. It is predicted that 
the Bs-PFK Arg-252 to Ala mutant enzyme will have little 
or no catalytic activity.
C. Significance of fls-PFK Research
The four mutations of Bs-PFK described above should 
give preliminary indications concerning the validity of the 
3-D structures proposed by Evans and colleagues at MRC 
Cambridge, England. Hellinga and Evans (1985) have 
cataloged 31 critical amino acid residues in Bs-PFK and 
described the roles which they appear to play in the 
function of the enzyme. It is anticipated that less than a 
dozen mutations should be necessary to confirm or disprove 
the structure-function relationships which they advanced 
based upon the crystal structures of the enzyme (Evans and 
Hudson, 1979; Evans et al., 1986).
The site-specific mutagenesis of Bs-PFK is expected 
to confirm the structure-function relationships proposed by 
Hellinga and Evans (1985) and enhance our understanding of 
this allosteric enzyme. This work will certainly be 
relevant to the study of RM-PFK because of the strong 
homology between the two enzymes (Poorman et al., 1984).
The understanding of structure-function relationships
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in Bs-PFK may also be relevant to other enzymes. For 
example, the positive cooperativity which results from the 
interaction between subunits may well be a common theme in 
nature. The cooperative oxygenation of hemoglobin (Perutz, 
1970) and the allosteric cooperativity of aspartate 
transcarbamoylase (Wente and Schachman, 1987) are notable 
examples of this phenomenon. Finally, it is interesting to 
note that proteins as diverse as ATP synthase, ATP/ADP 
translocase, adenylate kinase, and PFK all have similar 
adenine nucleotide binding folds in their structures 
(Walker et al., 1982).
II. RM-PFK Research
A. Immediate Goals
The expression of a eukaryotic gene in E. coli 
requires that the gene be free of introns. It will 
therefore be necessary to synthesize or construct a full- 
length cDNA of RM-PFK before expression can be attempted.
In cases where full-length cDNA's have been difficult to 
obtain directly, it has been necessary to splice partial 
cDNA’s and genomic fragments together’ in order to construct 
a full-length clone (Toole et a l ., 1984). Alternatively,
introns have been deleted from genomic clones by 
oligonucleotide-directed mutagenesis (Wallace et al.,
1980). Oligonucleotides may also prove useful as short 
linkers and structural units of cDNA.
It may prove necessary to pursue one or more of these
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experimental designs in order to obtain a full-length 
RM-PFK cDNA. Regardless of the approach chosen, pOB220/RM- 
pfk represents a significant contribution since it 
encompasses one-quarter of the RM-PFK coding sequence. The 
corresponding region of the genomic clone contains 5 of the 
22 known introns.
Once constructed, the full-length cDNA will be 
inserted into an expression vector under the control of an 
inducible prokaryotic promoter. The resulting hybrid gene 
should provide a reasonably high level of RM-PFK expression 
in E. coli. These manipulations will complete the system 
necessary for performing site-specific mutagenesis on 
RM-PFK.
B. Site-specific Mutagenesis of RM-PFK
A number of site-specific mutations have already been 
designed for RM-PFK. The initial mutations will focus on 
the locations of the fructose bisphosphate and AMP/ADP 
activation sites proposed by Poorman et a l . (1984).
Mutations have also been planned which will verify the 
function of the connecting peptide, probe the catalytic 
site, and determine if the N-terminal half of PFK is 
enzymatically active.
The proposed location of the fructose bisphosphate 
activation site will be investigated by substituting Asp 
for Ser-127C. Poorman et a l . (1984) have suggested that
the relatively small Ser-127 side chain leaves room in the 
activation site for the fructose 1,6- and 2,6-
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bisphosphates. The probable effect of substituting a 
carboxyl group for the hydroxyl group will be to reduce the 
enzyme’s affinity for these activators due to repulsion 
between the carboxyl group and PI or P2 of the fructose 
bisphosphates.
A series of mutations are planned to investigate the 
location of the ATP inhibition site. The mutations involve 
substituting Ala for Lys-211C, Lys-213C, Arg-21N, and Arg- 
25N. These residues hydrogen bond the phosphates of ATP, 
so the mutations should reduce the enzyme's affinity for 
this inhibitor. The effect should be cumulative for the 
double, triple, and quadruple mutants. The sensitivity to 
ATP inhibition displa5red by the multiple mutants should 
therefore be inversely proportional to the number of 
mutations at this site.
The techniques of oligonucleotide-directed 
mutagenesis and deletion mutagenesis will be combined to 
investigate the function of the connecting peptide in RM- 
PFK. The basic premise of the model proposed by Poorman et 
a l . (1984) is that the N- and C- terminal halves of each
RM-PFK subunit associate much like a dimer of Us-PFK. The 
peptide connecting these two halves provides the 
flexibility necessary for such an association.
The 30 amino acids from Lys-320N to Ala-5C form the 
connecting peptide of RM-PFK. In the first step of the 
procedure, a Hindlll site will be introduced at Lys-320 
using oligonucleotide-directed mutagenesis. The only other
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Hindlll site in the RM-PFK cDNA is located at Lys-334N. A 
Hindlll digestion of this mutant will therefore release a 
42 bp fragment encoding 14 amino acids of the connecting 
peptide. This fragment will then be replaced with double- 
stranded oligonucleotides of various lengths. These 
experiments will determine the minimal length of connecting 
peptide necessary for the proper tertiary .structure and 
function of RM-PFK.
The identity of the catalytic Asp-127N residue will be 
verified by substituting Ser for Asp. A personal 
communication from Hellinga and Evans at MRC Cambridge, 
England reported that the corresponding mutation in Ec- 
PFK-1 caused an 18,000-fold decrease in the kcat of that 
enzyme. The Asp-127N to Ser mutation in RM-PFK is expected 
to result in a similar decrease in catalytic activity since 
the carboxyl of Asp-127N probably serves as a general base 
in the reaction mechanism of RM-PFK.
Poorman et a l . (1984) proposed that the N-terminal 
half of RM-PFK serves a catalytic function while the C- 
terminal half has assumed an allosteric role. If this 
model is valid, there is a small chance that the N-terminal 
half of the enzyme will retain catalytic activity in the 
absence of the C-terminal half. This possibility will be 
investigated by making use of the unique Hindlll site in 
RM-PFK cDNA. The site corresponds to Lys-334N which 
defines the C-terminal end of the N-terminal half of RM- 
PFK. A double-stranded oligonucleotide containing a
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termination codon will thus be inserted after cleavage at 
this Hindlll site. The resulting mutant RM-PFK will 
consist of only the N-terminal half of each subunit and 
will therefore resemble the prokaryotic PF K ’s. There is a 
small chance that these mutant subunits will be capable of 
forming active tetramers. If this is the case and the 
model of Poorman et a l . (1984) is correct, then the mutant 
tetramers will no longer be sensitive to activation by ADP 
and the fructose bisphosphates.
C. Significance of RM-PFK Research
It is anticipated that the site-specific mutagenesis 
of RM-PFK will play a key role in supporting or disproving 
the model proposed by Poorman et a l . (1984). This model
for the locations of the fructose bisphosphate activation 
site and the AMP/ADP activation site is a reasonable one, 
and the site-specific mutagenesis may well provide evidence 
in its support. However, the model will be disproven if 
mutations at the proposed activation sites have no effect 
upon the kinetics of RM-PFK.
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